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“ Life in the microbial world is no picnic. Hard molecular rain falls incessantly from all sides, 
nutrients are scarce and unpredictable, experienced competitors lurk at every turn. Faced with 
continual life and death decisions, survival depends on cunning and quick reflexes.” Parkinson, 1993.
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1 Summary 
Hemotrophic mycoplasmas (HMs) are red blood cell (RBC) parasites that cause acute and chronic 
anemia in a variety of vertebrates. A hallmark of this group of cell wall-less, pleomorphic bacteria is 
their small genome and size. HMs depend on metabolic nutrients of their host for proliferation. As a 
consequence, a splenectomized animal model is necessary for HM propagation.  
Interestingly, reports on human infections have increased significantly, thereby indicating a zoonotic 
potential of hemotrophic mycoplasmas. Several HMs have been reported to play a role in immune 
mediated diseases for example, the pig specific Mycoplasma suis was shown to play a role in the 
development of systemic lupus erythematosus (SLE).  
M. suis infections are characterized by the lifelong persistence of the agent and development of 
pathological alterations e.g. hemorrhagic diathesis. The modulation of the host’s immune response 
helps M. suis to avoid destruction and to establish persistent infections. To date, detailed studies on 
immunomodulatory activity of M. suis are lacking due to the constraints linked to the animal model 
and the inability to cultivate M. suis in vitro.  
 So far it is only known that M. suis alters the in vitro immune response of lymphocytes from M. suis 
infected pigs. Firstly it inhibits a blastogenic response of T-lymphocytes. Secondly, it induces a 
polyclonal activation of B-lymphocytes that is characterized by the production of autoreactive IgM 
and IgG antibodies.  However, mechanisms mediating immune evasion have hitherto not been 
elucidated. This study focuses on the identification of immune system components that are targeted by 
M. suis and the documentation of infection induced pathologies.   
The interaction of M. suis with peripheral blood mononuclear cells (PBMCs) was analyzed in vivo and 
in vitro. In 12% of the PBMCs M. suis appeared as single or cluster of cells either on the inside or 
attached to their surface. The total PBMC count was considerably decreased and at the same time a 
widespread clotting of the blood occurred upon M. suis infection. 
In the present study three key events that characterize the immune modulation by M. suis were 
evidenced. Firstly, in the early phase of interaction M. suis induces a T-lymphocyte-independent 
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polyclonal activation of naive B-lymphocytes. Secondly, M. suis inhibits the T-helper cell mediated 
immune response via premature activation of T-regulatory cells. The suppression of the T-helper cell 
mediated immune response by T-regulatory cells derived IL-10, represents a mechanism responsible 
for the development of tolerance to M. suis antigens. Thirdly, macrophage derived IL-12 was 
down-regulated upon stimulation with M. suis. The down-regulation of IL-12 affects the development 
of type 1 immune response of T-helper cell (Th1) and the elimination of intracellular pathogens.  
In M. suis infected pigs intravasal coagulation and subsequent consumption coagulopathy were 
reported previously as mechanisms responsible for hemorrhagic diathesis and coagulation dysfunction. 
However they cannot fully explain the cascade of events responsible for the pathology. Therefore, the 
focus of the present study was to analyze the contribution of M. suis-endothelial cells (ECs) 
interaction to the subsequent hemorrhagic diathesis. The activation of ECs upon M. suis interaction 
in vitro was evidenced by flow cytometry analysis. The in vivo dysfunctional activation and 
widespread damage of ECs was documented using light and electron microscopy. Dysfunctional 
activation and disturbance of protective function of endothelial cells (ECs) upon M. suis infection was 
evidenced. Furthermore, M. suis single cells and microcolonies attached to the endothelium 
resembling biofilm formation were documented by electron microscopic analysis. Biofilm formation 
usually represents a persistence mechanism of bacteria. 
In conclusion this thesis provides first evidence that M. suis was not only found attached to 
erythrocytes and free in plasma but also attached to ECs and PBMCs. M.  suis induced leukopenia is 
attributed to the coagulopathy and it represents immune system impairment and supports the 
persistence of the agent. M. suis inhibits T-helper cell response, thereby preventing the generation of 
M. suis specific cellular immune response. Most probably, M. suis impairs macrophage function as 
indicated by the down-regulation of IL-12. The T-helper cell independent B-lymphocyte polyclonal 
activation by M. suis leads to the production of autoreactive antibodies, resulting in the autoimmunity. 
Dysfunctional activation and disturbance of protective function of endothelial cells upon M. suis 
infection leads to hemorrhagic diathesis and organ failure. Altogether we were able to identify key 
components of the immune response affected by M. suis in the early phase of infection which 
represents a crucial phase for the generation of a protective immune response. 
Ph.D. Thesis, Albina Sokoli 
 3  
2 Zusammenfassung 
Hämotrophe Mykoplasmen (HM) infizieren die roten Blutzellen verschiedener Vertebraten und 
verursachen dabei akute und chronische Anämien. Diese zellwandlose und pleomorphe Gruppe von 
Bakterien besitzt ein sehr kleines Genom. Die bislang  in vitro unkultivierbaren HM sind für ihre 
Vermehrung auf die Zufuhr von Wirtsmetaboliten angewiesen und können nur im splenektomierten 
Tiermodell vermehrt werden.  
Berichte über humane HM-Infektionen sind in den letzten Jahren signifikant angestiegen und weist auf 
ein zoonotisches Potential dieser Bakterien hin. Verschiedene HM-Vertreter spielen eine Rolle in 
immunvermittelten Krankheiten. So wurde z.B. beschrieben, dass Mycoplasma suis, das 
klassischerweise spezifisch Schweine infiziert, eine Rolle in der Entwicklung des Systemischen Lupus 
Erythematosus (SLE) beim Menschen spielen kann.  
Infektionen des Schweines mit M. suis sind durch eine lebenslange Persistenz des Erregers und durch 
die Entwicklung pathologischer Veränderungen, wie z.B. hämorrhagischer Diathese, charakterisiert.  
Durch die Modulation der Immunantwort des Wirtes wird die M. suis-spezifische Immunabwehr 
beeinflusst, was wiederum eine Persistenz des Erregers ermöglicht. Aufgrund der Einschränkungen im 
Zusammenhang mit dem Tiermodell und dem Fehlen eines in vitro Kultivierungssystems für M. suis, 
gibt es keine detaillierten Studien über immunmodulatorische Aktivitäten dieses Bakteriums.  
Es ist bekannt, dass M. suis die Immunantwort von Lymphozyten aus M. suis-infizierten Schweinen in 
vitro beeinflusst. Einerseits wird die Blastogenese der T-Lymphozyten inhibiert und andererseits wird 
eine polyklonale Aktivierung der B-Lymphozyten induziert, welche zur Produktion von autoreaktiven 
IgM und IgG Antikörpern führt. Die Mechanismen, die für die Immunmodulation und die 
Immunevasion verantwortlich sind, wurden bislang nicht aufgeklärt. Die vorliegende Arbeit fokussiert 
daher auf die Identifizierung der Immunsystem-Komponenten, die von M. suis beeinflusst und 
moduliert werden, sowie auf der Aufklärung von pathologischen Veränderungen, die durch eine 
M. suis-Infektion verursacht werden. 
Die Interaktion von M. suis mit mononukleären Zellen des peripheren Blutes (PBMCs) wurde in vivo 
und in vitro untersucht. Bei 12% der PBMCs konnte M. suis als einzelne Zelle oder in Form von 
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Clustern auf oder in Zellen in vivo nachgewiesen werden. Die Gesamtzahl der PBMCs in infizierten 
Schweinen war deutlich vermindert und gleichzeitig trat eine erhöhte Blutgerinnung auf. 
Insgesamt wurden durch die vorgelegte Studie drei für eine Immunmodulation durch M. suis 
entscheidende Charakteristika, nachgewiesen:  
1. In der frühen Phase der Interaktion induziert M. suis eine T-Lymphozyten-unabhängige polyklonale 
Aktivierung der B-Lymphozyten.  
2. M. suis inhibiert die T-Helferzellen-vermittelte Immunantwort durch frühzeitige Aktivierung der 
regulatorischen T-Zellen, welche IL-10 produzieren. Die Hemmung der durch T-Helferzellen 
induzierten Immunantwort durch IL-10 repräsentiert einen Mechanismus, der für die Entwicklung der 
Toleranz gegenüber M. suis-Antigenen verantwortlich ist.  
3. IL-12, das durch Makrophagen produziert wird, wurde nach der Interaktion mit M. suis 
herunterreguliert. Diese Herabregulation von IL-12 beeinflusst die Entwicklung der 
T-Helferzellen-vermittelten Immunantwort des Typs 1 (Th1) und somit die Eliminierung von 
intrazellulären Pathogenen.  
Als Ursachen für die während M. suis-Infektionen beobachteten Gerinnungsstörungen und 
hämorrhagischen Diathesen wurden in einer früheren Studie eine intravasale Gerinnung mit 
anschliessender Verbrauchskoagulopathie identifiziert. Jedoch konnten durch diese 
Pathomechanismen nicht alle M. suis-induzierten Veränderungen erklärt werden. Das Ziel dieser 
Studie war daher, die Interaktion von M. suis mit Endothelzellen (EZ) im Hinblick auf die Entstehung 
der hämorrhagischen Diathese zu analysieren.  
Licht- und Elektronenmikroskopisch konnten in infizierten Schweinen grossflächige Veränderungen 
und Zerstörungen des Endothels nachewiesen werden. Ausserdem wurde mittels  
Durchflusszytometrie eine massive Aktivierung von EZ in vitro demonstriert werden 
Diese grossflächige und massive Aktivierung sowie die pathologischen Veränderungen  der EZ sind 
aufgrund der Studienergebnisse ursächlich für Hämorrhagien und Dysfunktionen der Organe. Zudem 
konnten mittels elektronenmikroskopischer Analyse einzelne M. suis-Zellen und biofilmähnliche 
M. suis-Mikrokolonien in enger Assoziation mit dem Endothelium dokumentiert werden. Die Bildung 
von Biofilmen ist als Persistenzmechanismus bekannt.  
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In dieser Arbeit wird zum ersten Mal gezeigt, dass M. suis nicht nur, wie bisher angenommen, mit 
Erythrozyten interagiert oder frei im Plasma zu finden ist, sondern auch in enger Assoziation mit 
Endothelzellen und PMBCs. Die M. suis-induzierte Leukopenie wird der Koagulopathie 
zugeschrieben und trägt zu einer Schwächung des Immunsystems  bei, was wiederum die 
Erregerpersistenz begünstigt.  
M. suis inhibiert die durch T-Helferzellen vermittelte Immunantwort wodurch die Entwicklung einer 
zellulären, M. suis-spezifischen Immunantwort verhindert wird. Die Herunterregulation von IL-12 
weist zudem auf eine Inhibierung der Makrophagenfunktion hin. Die T-Helferzellen-unabhängige 
polyklonale Aktivierung der B-Lymphozyten durch M. suis führt zur Produktion autoreaktiver 
Antikörper. Die dysfunktionale Aktivierung und die Beeinträchtigung der schützenden Funktion der 
EZ durch die M. suis-Infektion führen zu hämorrhagischer Diathese und Organfehlern.  
In dieser Arbeit konnte gezeigt werden, dass drei Komponenten der Immunantwort in der frühen 
Phase der Interaktion von M. suis beeinflusst werden. Die frühe Phase der Interaktion ist  entscheidend 
für die Entwicklung einer schützenden Immunantwort.  
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3 Introduction 
3.1 The genus Mycoplasma 
Mycoplasmas are phenotypically distinguishable from all other bacteria by the lack of cell wall and 
the minute size and genome [1, 2]. Because of the lack of the cell wall mycoplasmas are clustered in 
the class of Mollicutes (lat. – soft), which is classified within the phylum of Tenericutes and consists 
of more than 250 species [3, 4]. The genus Mycoplasma comprises pathogens of mammals, birds, 
reptiles, arthropods, plants, and fish [2]. Infections with mycoplasmas are associated with retroviral 
and autoimmune diseases [5, 6]. Mycoplasmas evade or suppress their host defense mechanisms either 
directly by invading and destroying immune cells (e.g. antibody presenting cells) or indirectly by 
inducing autoimmunity, mitogenicity, modulation of cytokine expression levels, etc. [1]. 
Mycoplasmas are species characterized by an extremely A-T rich chromosome and the smallest 
genome of any independently replicating organism [7-11]. Their uniqueness comes in addition to the 
small chromosome by the exceptional codon usage. In mycoplasmas, the stop codon, TGA is used as 
tryptophan encoding codon instead [2, 12].  
The genera of Eperythrozoon and Haemobartonella were previously classified within the order 
Rickettsiales as member of the family Anaplasmataceae. Based on the phenotypical and phylgenetical 
characteristics, these two genera were found to be more closely related to the class Mollicutes [13]. 
Therefore they have been reclassified to the genus Mycoplasma (pneumoniae group) building the 
distinct new cluster of hemotrophic mycoplasmas [13, 14].  The classification was based on RNA 
sequence analysis and phenotypic characteristics [1, 3, 14, 15].  
 
3.2 Hemotrophic mycoplasma  
The Hemotrophic mycoplasma (HM) cluster consists of pleomorphic red blood cell (RBC) parasites 
that infect a wide range of animals and cause hemolytic anemia [13, 16, 17].  
A common feature of HMs is their ability to attach to the surface of host RBC and parasitize them [12, 
17, 18]. They have a variable morphology appearing as rings, coccoids or short rods of 0.3 to 3 
microns in diameter [16, 19]. Hence, cell wall targeting antimicrobial agents do not eliminate HMs, as 
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they do not have a cell wall [1, 13]. The HMs are not cultivable in vitro so far, and as a consequence 
thereof little is known about their pathogenic mechanisms [13, 20]. This group of bacteria is highly 
adapted to their host. Their adaptation is characterized by complex nutritional requirements, induction 
of persistent infection, and modulation of the host immune responsiveness [13, 16, 20, 21]. Nutritional 
dependence of HMs on complex host cell metabolism is responsible for the lack of in vitro HM 
cultivation system [16].  
In 1928 Dr. Schilling identified, for the first time, mouse- and dog-specific HMs (E. coccoides, 
H.  canis) [22], since then species-specific HMs have been described in the blood of several animals 
(cat, mouse, rat, sheep, goat, cattle, pig, opossum, llama, horse, and squirrel monkey) [13, 23]. 
Recently, a new human-specific species was described which presented clinical signs similar to those 
characterizing HM infections in other vertebrates [24].  
Infections with pig specific Hemotrophic Mycoplasma suis (M. suis) are common among livestock and 
cause considerable economic losses [25]. In 2008 a report evaluating the prevalence of M.  suis found 
up to to 40 % infection in German pig farms [25]. 
The zoonotic potential of HM has been reported several times in the past [13, 16, 26, 27]. M. suis was 
found in 49 % of tested swine-farm workers in Shanghai [28]. Other zoonotic HM infections reported 
include an HIV positive patient infected with Mycoplasma haemofelis in Brazil and a veterinarian was 
infected with Mycoplasma ovis in California [29, 30]. 
It is noteworthy that HM - infections are associated with autoimmune and retroviral diseases [16].  
 
3.3 Mycoplasma suis (M. suis) 
The porcine pathogen M. suis is able to adhere to the surface of RBCs and even to invade them in an 
endocytosis-like process [13, 18]. M. suis appears in coccoid, discoid, and ring form of approximately 
200 nm in diameter in association with RBCs or free floating in the plasma [31].The close contact 
between RBCs and M. suis is characterized by the presence of a 30 nm lucent zone and fine fibrillar 
attachments between the two interacting partners [13]. 
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Little is known about microbial, virulence and persistence mechanisms of M. suis since an in vitro 
cultivation system has not been established [12, 20, 32, 33]. Therefore, the splenectomized pig, a 
well-established animal model, is used to propagate M. suis [34]. In this in vivo model all relevant 
clinical and microbiological parameters of a natural infection can be simulated [35]. These include: 
hypoglycemia, immune-hemolytic anemia, autoreactive antibody production, cyanoses, immune 
modulations, pathogen persistence, and circulatory disturbances [13, 36].  
M. suis, like other members of HMs, has a very small genome (709 Kb) for a self-replicating 
organism [21]. The small genomic size indicates the loss of genetic information for different 
biosynthesis pathways and explains M. suis requirements for host nutritional molecules [20, 21, 37].  
The recent in silico genomic analysis predicts M. suis ability to catabolize glucose and synthesize 
purines from hypoxanthine [37], which is in line with the results from the proteome analysis [20]. Like 
other mollicutes, M. suis is not capable of de novo synthesis of nucleotides and coenzymes and must 
therefore import them from the host [20, 37]. The lipid metabolism is also restricted according to 
genomic and proteomic analysis [20, 37]. These results further support the suggested HM evasion 
strategy, which consists of HMs coating itself with parts of the host membrane [31].  
 
3.4 Infectious anemia in pig (IAP) 
As a consequence of complex nutritional dependence on the host, M. suis is bound to a parasitic 
lifestyle and represents the causative agent of either acute or chronic IAP [13, 38]. The acute course of 
M. suis induced hemolytic anemia is severe and leads to death, whereas mild anemia, ill thrift, 
infertility, and immune suppression are features of the chronic course of the disease [13, 31, 36]. 
Immune suppressed animals and suckling piglets suffer acute course of hemolytic anemia [37]. The 
chronic course of the infection signed for instance by a higher susceptibility to infections of the 
gastrointestinal and the respiratory tract has a great economic impact in livestock production [13, 36]. 
Clinical patterns of the chronic course of the disease result from the ability of M. suis to persist 
life-long and cause modulation of host immune system including autoimmunity induction [33, 39]. 
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Host immune response to M. suis 
Alteration and deformation of RBCs during M. suis infection induce the production of anti RBC 
autoantibodies that are responsible for clinical signs e.g. acrocyanosis and pallor [33, 36, 40-42]. 
Proteome and immunome analysis performed by Hoelzle and co-workers identified M. suis antigens 
expressed during IAP. They were targeted by porcine IgGs [12, 40, 41, 43-45]. These immunogens 
were identified as two heat shock proteins (DnaK, GroEL), two glycolysis enzymes (enolase, pyruvate 
dehydrogenase), one RNA helicase and an actin-analogous protein [40]. Further analysis characterized 
the following 3 antigens as moonlighting proteins: HspA1 (Heat shock protein A1), MSG1 
(M. suis GAPDH-like protein 1), and α-Enolases. The first has a chaperonin and cell adhesion 
function. The last two have glycolytic and cell adhesion function [12, 40, 45].  
In the acute phase of immune mediated hemolytic anemia an increase of autoreactive IgG antibodies 
and a decrease of M. suis-specific antibodies was observed [41]. Further analysis identified 
autoreactive antibodies of IgG isotype directed to host actin [13, 39]. In addition, immunization with 
recombinant MSG1 was shown to induce production of auto-actin- antibodies in pigs, indicating a role 
of MSG1 in induction of autoimmunity by molecular mimicry [39]. 
M. suis infections affects both B- and T-lymphocyte response as determined in vitro by 3(H)thymidine 
incorporation assay [36]. The polyclonal activation of T-lymphocytes from M. suis infected pig was 
inhibited in vitro. Against it, B-lymphocytes were activated in a polyclonal manner in vitro. 
 
3.5 Immune system 
The immune system is composed of organs and cells that collaborate to protect the multicellular 
organism from invading pathogens [46, 47]. Immunity refers to the condition in which an organism is 
protected from foreign organisms [47]. In vertebrates two types of immune systems operate 
cooperatively to protect the organism: the acquired immune system, and the phylogenetically ancient 
innate immune system [46, 48].   
The innate immune system is the first line of the defense with limited specificity that allows 
recognition of molecular motifs on the surface of microbes (pathogen associated molecular patterns, 
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(PAMPs)) [49]. In contrast, the acquired immune system needs more than 4 days upon pathogen 
encounter to develop maximum efficacy [46]. Nevertheless, receptors of the acquired immunity are 
formed by genetic recombination and recognize specific details of molecular structures, thereby 
conferring very high specificity and ability to recognize any possible pathogen [46]. 
 
3.6 Innate immunity 
Cellular constituents of innate immunity are: macrophages, natural killer cells (NK cells), 
granulocytes (neutrophils, eosinophils, basophils), and dendritic cells (DC) [46].  
Macrophages recognize PAMPs on microbes via toll like receptors (TLR) and phagocytize them [50]. 
The phagocytized pathogens are lysed and the processed peptides of the pathogen (antigens) are 
presented to the T-lymphocytes on major histocompatibility complex (MHC) molecules [51]. 
Activated macrophages also produce proinflammatory cytokines: interleukin-1 (IL-1), -6 (IL-6), and 
tumor necrosis factor alpha (TNF-α). In addition, macrophage derived interleukin-12 (IL-12) is 
responsible for the development of naive T-lymphocytes to T-effector cell of type 1 (TH1) [52, 53]. 
The very effective feature of macrophages and neutrophils against pathogens is the inducible nitric 
oxide synthetase (iNOS) that is responsible for the production of antimicrobial active nitric oxide 
(NO) [46]. However, higher levels of NO and reactive oxygen species (ROS) produced by 
macrophages and neutrophils are associated with immunopathologies e.g. tissue injury, inhibition of 
T-cell proliferation in DP-BB rats, and type 1 autoimmune diseases [54-58].  
Neutrophils and eosinophils eliminate invaders either by phagocytosis or by releasing the toxic 
substances from their granules [59]. Basophils do not phagocytize and release only pharmacological 
active substances e.g. histamine [59]. Granulocytes are important in the defense against helminthes but 
have also been associated with immunopathologies e.g. allergy, corneal haze, tropical pulmonary 
eosinophilia, candidiasis [60].  
Granular lymphocytes are natural killer cells (NK). NK are very effective in killing virus infected, 
altered host cells or antibody marked cells via antibody dependent cell - mediated cytotoxicity 
(ADCC)) [61, 62]. IFN-γ and TNF-α production by NK cells activates dendritic cells [63]. 
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Dendritic cells (DCs), also known as professional antigen presenting cells (APCs), are the key link 
between innate and acquired immunity [46]. DCs phagocytize antigens (pathogen), process, and 
present antigens to naive T-lymphocytes [64]. DCs are the only APCs that can induce primary 
immune response via antigen presentation and T-lymphocyte activation [64]. In addition DCs activate 
resting B-lymphocytes by transferring the processed antigen to B-lymphocytes [65, 66].  
 
3.7 Acquired immunity 
Acquired immunity consists of T (thymus-derived) and B (bursal or bone marrow–derived) 
lymphocytes [67]. Both cell types have highly specific receptors that recognize details of molecular 
structures from a variety of pathogens [46]. This high diversity (5 x 1016 antigen specific receptors) is 
generated through rearrangement of immunoglobulin gene segments [46, 68, 69]. The diversity is 
generated in order to recognize a high number of pathogens displaying non-self-structures. However 
T- and B-clones recognizing self-structures are inactivated in the periphery or eliminated in the 
thymus and bone marrow, respectively [46, 70]. The inactivation or elimination of self-reactive T- and 
B-lymphocytes results in the so-called self-tolerance [71]. When self-tolerance is lost, an immune 
response directed against self-antigens develops resulting in autoimmunity [72]. Factors contributing 
to autoimmunity include the release of cryptic antigens, genetic predisposition, and infections with 
pathogens [46].  
 
3.8 B-lymphocytes  
B-cells recognize and internalize whole antigens via B-cell receptor (BcR) mediated endocytosis [46]. 
The internalized antigen is processed and presented to antigen specific T-lymphocytes on 
class II MHC molecules. The activated T-lymphocyte activate B-lymphocytes [46]. The activated 
B-lymphocytes proliferate to amplify the antigen specific immune response and secrete low affinity 
antibodies of class IgM [73]. Upon interaction of antigen specific B- and T-lymphocytes a class switch 
from IgM to IgG isotype occurs [46, 74]. In addition, B-lymphocytes undergo somatic hypermutation 
of immunoglobulin genes, thereby generating high affinity antibodies of IgG isotype [75]. This 
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process is known as affinity maturation and is driven by the mechanisms of somatic hypermutation 
and selection of high affinity clones [76]. The B-lymphocytes develop either into antibody producing 
plasma cells or memory cells that respond very fast with the production of antigen specific IgG 
antibodies upon secondary encounter of the same antigen [46, 77]. 
Some antigens are able to activate B- lymphocytes in a T-lymphocyte independent manner [78]. In 
addition to proinflammatory cytokines, TNF-α and IL-6, B-lymphocytes produce also IL-10, in order 
to suppress the T-lymphocyte immune response driven autoimmunity [79]. Immunopathologies 
associated with self-reactive B-lymphocytes are e.g. rheumatoid arthritis, systemic lupus 
erythematosus  (SLE), multiple sclerosis [80, 81].  
 
3.9 T-lymphocytes  
Functionally different T-cell subsets, like cytotoxic, helper, and regulatory cells represent the cellular 
branch of acquired immunity [46].  
Cytotoxic T-lymphocytes (CTL) get activated upon interaction with antigen presented on class I MHC 
molecules of APCs [82]. For the CTL activation the presence of IL-2, which is produced by effector 
T-lymphocytes, is essential [46]. Primed CTL clonally expand and induce apoptosis of infected or 
altered (tumor) cells either directly via fas/fasL pathway or indirectly by release of cytotoxins [83, 84]. 
Increased number of CTLs is associated with the outcome of sepsis and immunopathologies during 
viral infections [85, 86]. 
T-helper (Th) cells are involved in T-dependent antibody production by B-lymphocytes. They are also 
involved in the activation of CTLs as well as innate immune cells [74, 87].   
Upon interaction with presented antigen on APCs and co-stimulatory signals, T-helper cells get 
activated and proliferate [87].  Depending on targeted antigen and cytokine environment, T-helper 
cells develop into one of the three in human and mice known subsets, namely Th1, Th2 and Th17 [88]. 
In pigs, only Th1 and Th2 subsets have been described [89]. These subsets orchestrate the acquired 
immune response to maintain the balance between protective and pathological immune response. Both 
cell subsets Th1 and Th2 are defined through distinct secreted cytokine profiles [87, 88].  
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3.10 Th1 and Th2 response 
Th1 cell subsets produce IFNγ and IL-2, activate macrophages and ensure survival of memory CTLs 
[46]. Activated macrophages produce NO, ROS and IL-12, whereas the latter inhibits the development 
of Th2 response and favors Th1 subset development [53]. An appropriate Th1 immune response is 
very effective in killing bacteria, protozoa, viruses and fungi. But, an overwhelming response of Th1 
type leads to tissue damage and autoimmunity [46, 88].  
Th2 cells produce IL-4 and IL-13, activate granulocytes and tissue repairing macrophages. They also 
induce class switch of IgG production by B-lymphocytes [46]. Th2 mediated immune response is 
beneficial in clearance of nematodes and infections with persistent antigens [53, 88]. However, the 
overshooting response of Th2 type is associated with allergy development. The outcome of the disease 
depends on the Th1 and Th2 effector response generated [46]. Previous studies have shown that the 
activation of one of the 2 response types is essential to defeat the invader, whereas the other one is 
rather harmful or even fatal [88]. For example, Th2 immune response elicited by BALB/c mice to 
Leishmania major infection proves fatal. Other mice strains develop Th1 immune response 
characterized by iNOS induction in macrophages. These mice strains in contrast to BALB/c mice heal 
from the infection [90-92].  
Mycobacterium tuberculosis (M. tuberculosis) infection represents an example were the precise 
balance between Th1 and Th2 response is critical for the outcome of the disease [88]. Th1 immune 
response with activated macrophages is necessary to keep the intracellular infection under control and 
to form granulomas [93, 94]. Concurrent Th2 immune response is required to prevent tissue damage 
from overshooting Th1 immune response [88, 95]. However a premature Th2 immune response to 
M. tuberculosis leads to enhancement of the disease, immunopathology, weight loss, and fibrosis [96]. 
The Th1-to-Th2 shift was shown to depend on the load of heat-killed (HK) Mycobacterium bovis 
bacillus Calmette-Guerin (BCG). Lower bacterial load induces the protective Th1 immune response. 
Whereas, a higher doses of HK-BCG induces a shift to Th2 immune response, which is characterized 
by the production of antibodies to mycobacterial 65-kDa (hsp60) heat shock Protein [97]. Antibodies 
to HSP65 are described to cross react with host heat shock proteins and to play a role in autoimmune 
diseases [97].  
Ph.D. Thesis, Albina Sokoli 
 14  
T-regulatory (Treg) cell subset represents an additional mechanism of peripheral tolerance. They 
down-regulate the amplitude of an immune response to prevent inflammation and autoimmunity. 
T-regulatory cells suppress T-helper cells via cell-cell contact (Fas and Granzyme B), production of 
soluble suppressive factors (IL-10; TGF-β) and competition for growth factors [46, 98]. 
 
3.11 Endothelium and pathogens 
Endothelium lines the inner layer (intima layer) of blood vessels and is composed of endothelial cells  
(ECs) that are connected via intercellular junctions to enable specific permeability [99, 100]. 
Endothelial cells are type of epithelial cells and are involved in immune response processes [99]. 
A study of Wang and co-workers evidenced the existence of embryonic precursor of endothelial and 
hematopoietic (multipotent blood cell precursors) cells. This report supports the view of the 
endothelium as an immunological organ [99, 101].  
The endothelium is a dynamic organ and a barrier between vascular space and surrounding tissue [99, 
102]. The house-keeping functions assigned to endothelium are vasoregulation, maintenance of blood 
circulation, coagulation, control of nutrients exchange, and inflammatory responses [102, 103]. 
The epicellular or intracellular interaction of pathogens with ECs induces the secretion of 
proinflammatory cytokines, chemokines, and the expression of cell adhesion molecules (CAMs), 
resulting in an inflammatory and procoagulant phenotype of ECs [102, 104].  
Several pathogens are able to trigger inflammatory responses and coagulation processes and disrupt 
the protective function of the endothelium [105]. Pathologies associated with endothelium targeting 
pathogens are: inflammation of the endothelium, intravascular coagulation and multiple organ 
dysfunctions, severe sepsis, septic shock, and hemorrhagic diathesis (bleeding tendency) [105].  
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4 Objectives of the thesis 
The hemotrophic Mycoplasma suis is the most common cause of acute and chronic infectious anemia 
in pig (IAP) [33]. Due to the unculturability of M. suis in vitro the knowledge about the underlying 
pathomechanisms is rather basic. M. suis establishes persistent infections in pig by evading and 
modulating the host immune responsiveness [13, 16].  
To date, only few pieces of the persistence puzzle are identified e.g. immunomodulatory effects as a 
result of M. suis infection have been shown on both T- and B-lymphocytes. M. suis infections have 
been shown to suppress T-lymphocyte blastogenic responses, indicating an alteration of T-helper 
lymphocyte activities [36]; Parallel to this, M. suis infections also lead to a polyclonal B-lymphocyte 
activation and the production of autoreactive IgM (cold agglutinins) as well as warm autoreactive IgG 
antibodies [13].  
 To fully understand the mechanisms of M. suis induced immune modulation, the immunomodulatory 
effect of M. suis on host immune response components needs to be clarified.  
In addition, IAP is accompanied with hemorrhagic diathesis ,coagulation dysfunction, petechial 
bleeding and ecchymosis [106] These clinical signs were attributed to intravasal coagulation and 
subsequent consumption coagulopathy in one former study [106]. However they cannot fully explain 
the process responsible for the pathology. Endothelial cells are known to be a key barrier in 
physiologically intact hosts [105], and the disturbed protective function of endothelial cells almost 
certainly leads to the development of hemorrhagic diathesis and disseminated coagulation in M. suis 
infections.  
The aim of this thesis was to analyze M. suis-host interaction in order to get more insights into the 
mechanisms underlying modulation of host immune responsiveness and induction of hemorrhagic 
diathesis in M. suis infections. 
 
Objective 1.  Modulation of the host immune responsiveness by M. suis infection 
The first research question addressed in this thesis concerned the identification of immune system 
components that are targeted by M. suis. The performed analysis aimed at elucidating the effect of 
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M. suis on immune response via direct interaction of M. suis with immune cells (e.g. invasion and 
direct damage) or indirect mechanisms (e.g. alteration of the cytokine expression profile). 
 
Objective 2. The role of endothelial cells in development of hemorrhagic diathesis during M. suis 
infection.  
This part of the thesis includes the analysis of the interaction of M. suis with endothelial cells, the 
elucidation of EC response to the infection, and the influence of the endothelial activation on 
coagulopathy. 
 
The study dealing with “Objective 2” is attached as a manuscript: Sokoli A, Groebel K, Hoelzle K, 
Amselgruber WM, Mateos JM, Schneider MK, Ziegler U, Felder KM, Hoelzle LE. (2012). 
Mycoplasma suis infection results endothelial cell damage and activation: new insight into the 
cell tropism and pathogenicity of hemotrophic mycoplasma. Veterinary Research submitted "under 
review“. 
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4.1 Objective 1.  Modulation of the host immune responsiveness by M. suis infection 
 
4.1.1 Materials and Methods 
4.1.1.1 Experimental infection 
M. suis infection of pigs was performed in accordance with Swiss legislation for animal welfare 
(Veterinary Office of Zurich, Switzerland; approval 55/2007; 68/2009). 
Weaned 4-week-old piglets (N = 4) were housed in the stables of the Institute for Veterinary 
Bacteriology, University of Zurich, Switzerland. The M. suis negative health status was confirmed by 
a quantitative PCR [32] and ELISA [107]. After two weeks the pigs were splenectomized as described 
by Heinritzi, 1990 [35] and allowed to recover for additional two weeks. At the age of 8 weeks pigs 
were infected with M. suis. Pig No 6019 was infected intramuscularly with 2 ml of M. suis positive 
blood (106 cells/ml) and developed acute course of the disease. In order to obtain the chronic course of 
the disease the pig No 6043 was infected orally (using M. suis contaminated food ≈ 1012 cells/ml). For 
infection, strain 3804 [GenBank: FN984917.1] was used. Daily, the feeding behavior, body 
temperature, and clinical signs were documented [18]. The clinical status of each pig was assessed 
using a scoring system described by our group [41]. The score one was given for the occurrence of one 
of the following clinical signs: fever (> 40 °C), reduced food uptake, lethargy, pale skin, and ear 
necrosis. Upon occurrence of four clinical signs per day the score four was given and the pig was 
treated with tetracycline (40 mg/kg body weight) and glucose (35 g/l drinking water), or euthanized. 
M. suis-negative pigs were monitored similarly.  
 
4.1.1.2 M. suis antigen preparation 
For the in vitro experiments, M. suis cells were purified from the blood of an experimentally infected 
pig as described before [43]. Briefly, EDTA anticoagulated blood was centrifuged at low speed 
(500 x g for 20 min at room temperature (RT)) to separate blood cells from the plasma. The 
supernatant containing M. suis cells was centrifuged at high speed (20` 000 x g) for 1 h at 4 °C 
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(Hettich Rotixa/AP; Hettich, Germany).  The pellet was washed once (same conditions) with ice-cold 
phosphate buffered saline (PBS, Biochrom). The M. suis load was quantified by quantitative PCR 
analysis (LightCycler™ 2.0 System; Roche Diagnostics, Switzerland; [32]. Blood from an 
M. suis-negative pigs was prepared accordingly to obtain the negative control preparation. M. suis 
antigen and negative control preparation were suspended in PBS and stored in 1 ml aliquots at -80 °C 
until use. 
 
4.1.1.3 PBMCs 
Peripheral blood mononuclear cells (PBMCs) are blood cell with a round nucleus. PBMCs consist of 
following cell population: The T- and B-lymphocytes, natural killer (NK) cells, monocytes, dendritic 
cells. PBMCs were extracted from fresh blood of M. suis infected pigs and from M. suis-negative pigs 
using Vacutainer cell preparation tubes (BD Biosciences, Switzerland) according to manufacturer’s 
instructions.  
The PBMCs from M. suis-negative pigs used for the in vitro stimulation assays were cryopreserved 
using 10 % dimethyl sulfoxide (DMSO, Sigma-Aldrich, Switzerland) and stored at -150 °C until use.  
The PBMCs used for flow cytometry and light microscopy analysis were fixed in 4  % Formaldehyde 
(FA, Biochrom, Switzerland) in phosphate-buffered saline (PBS, pH 7.3) for 2 h at RT. FA fixed 
PBMCs were stored in PBS at 4 °C until further processing. 
For scanning electron microscope (SEM) analysis, PBMCs were seeded on cover slips in a 12-well 
tissue culture plate. PBMCs were incubated in RPMI 1640 medium (Roswell Park Memorial Institute; 
Biochrom, Switzerland) supplemented with 10 % inactivated fetal calf serum (FCS, Biochrom) and 
50 mg/ml ampicillin.  After 24 h of incubation at 37 °C the adherent PBMCs were fixed in 2.5 % 
phosphate-buffered glutaraldehyde (GA, Sigma, Switzerland) for 2 h. GA fixed PBMCs were stored in 
PBS at 4 °C until further processing. 
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4.1.1.4 Scanning electron microscopy of PBMCs 
The GA fixed PBMCs (adherent on cover slips) were post-fixed in 1 % osmium tetroxide 
(Fluka Chemie, Switzerland) for 1 h at RT and were then dehydrated in graded-ethanol series. The 
dehydrated PBMCs were critical point dried (BAL-TEC CPD 030, Critical Point Dryer, Balzers, 
Liechtenstein) and coated with 12 nm of platinum using the BAL-TEC MED 020 coating system. The 
samples were mounted on aluminum stubs and analyzed on a Zeiss Supra 50 VP (Zeiss, Germany).  
 
4.1.1.5 Apoptosis and necrosis assays 
Naive and activated PBMCs were stimulated with purified M. suis antigen preparation 
(104 M. suis cells/ml) for 2, 24, and 48 hours. In order to test the immune response of PBMCs to 
M.suis in activated versus naive state 100 ng/ml lipopolysaccharide (LPS, Sigma-Aldrich, 
Switzerland) was used to induce the activated state of PBMCs [108].  M. suis negative blood 
preparations were used as a negative control. LPS at the concentration of 50 µg/ml was used as a 
positive control (R Otton 2004 diabetes). For the staining procedure Annexin-V-FLUOS Staining Kit 
(Roche, Switzerland) was used. With Annexin-V early stages of apoptosis are detected because it 
binds to phosphatidyserines, which are translocated from the inside to the outside of the plasma 
membrane in the very early stage of apoptosis. To detect necrosis propidium iodide was used which 
stains DNA only in permeabilized cells. Cells were analyzed for apoptosis by measuring the amount 
of bound AnnexinV- FITC or propidium iodide staining of the nucleus with flow cytometry 
(FACS Canto, BD Bioscience, Switzerland). Single Annexin-V-FITC stained cells were considered 
apoptotic. Cells stained with propidium iodide or with propidium iodide and Annexin-V-FITC were 
considered necrotic.  
 
4.1.1.6 Analysis of in vivo M. suis – PBMCs interaction  
FA-fixed PBMCs from experimentally infected pigs were permeabilized for 20 min using 
saponin-containing buffer (perm/wash buffer, BD Bioscience, Switzerland). Non-reacted aldehydes 
were blocked for 10 min with 0.1 M glycine (Carl Roth, Germany) in perm/wash buffer. To reduce the 
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unspecific binding of antibodies cells were incubated for 1 h in blocking buffer (3 % BSA in 
perm/wash buffer).  
M. suis was specifically stained for 2 h using an anti-MSG1 mouse monoclonal 
antibody  (diluted 1:100 in staining buffer, i.e. 1 % BSA in perm/wash buffer). The anti-MSG1 
monoclonal antibody had been produced in our laboratory. The unbound antibodies were removed by 
washing the cells three times with perm/wash buffer. Cells were then incubated for 1 h with 
alexa-fluor 647 conjugated goat anti mouse IgG (diluted 1:1000 in staining buffer Sigma-Aldrich, 
Switzerland). Finally, the PBMCs were washed three times with perm/wash buffer to remove free 
antibodies.  
M. suis positive PBMCs were quantified by flow cytometry (FlowSight, Merck Millipore, 
Switzerland). To sort the M. suis positive PBMCs from M. suis negative ones, the fluorescence 
activated cell sorting aria III (FACS aria III) flow cytometer was used (BD Bioscience, Switzerland). 
Actin from the sorted M. suis positive and negative PBMCs was stained using phalloidin-FITC 
(1:80 in PBS, Invitrogen, Basel, Switzerland).  
Stained cells were centrifuged (cytospin 2, Shandon, Pittsburgh, USA) for 5 min at 1200 g to 
coverslips that were subsequently mounted on slides using antifade mounting medium 
(Dabco mounting medium, Sigma-Aldrich, Switzerland).   
Samples were analyzed using a confocal laser-scanning microscope Leica SP5 (CLSM, Leica 
Microsystems). The microscopic images were processed using Imaris 7.5.2 (Bitplane, USA) and 
Adobe Photoshop CS5.  
 
4.1.1.7 M. suis specific proliferation assay 
To test the actual proliferation frequency that occurs in naive cells, PBMCs were stained with 5 mM 
carboxyfluorescein succinimidyl ester (CFSE, Santa Cruz, USA) as described elsewhere [89]. Briefly, 
5 - 6 x 105 PBMCs per well were incubated with purified M. suis antigen (≈ 104 M. suis cells) for 
2, 3, and 5 days. As a positive control LPS at a concentration of 100 ng/ml was used. The blood 
preparation from M. suis negative pig was used as a negative control. The CFSE dilution assay reflects 
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the proliferation profile of each PBMC subset since the intensity of the detected fluorescence signal is 
halved with each cell division. 
PBMCs of different functionalities are distinguished by the presence of subtype specific receptors on 
their surface. These receptors are called cluster of differentiation (CD) and used as markers in 
immunophenotyping [109]. T-helper cells and cytotoxic T-lymphocytes (CTLs) are CD4+ and CD8+, 
respectively. The B-lymphocytes express CD21 on their surface. 
PBMCs were labeled primary with mouse anti – pig CD4, CD8, and CD21 (1:100; Santa Cruz 
Biotechnologies, USA) and secondary with goat anti mouse IgG conjugated to apc - Cy7 (1:1000) 
(Santa Cruz Biotechnologies, USA). The obtained data were analyzed with FlowJo 7.6 software 
(TriStar, USA). The FlowJo software was used to generate the proliferation profile models and to 
calculate the proliferation index (PI). The PI results from the calculation of the total number of 
divisions that occurred divided by the number of cells that divided. 
 
4.1.1.8 In vitro stimulation of PBMCs and cytokine production 
To characterize the type of a given immune response (e.g. T-helper 1 and 2 cell balance) cytokine 
profiles were indirectly measured. Namely, the cytokine positive cells were quantified and compared 
to the negative control. The cytokines included in this study are the Th1 and Th2 defining cytokines 
(IFN-γ; IL-4; IL-10; IL-12), the proinflammatory cytokines (IL-1; IL-6; TNF-α) and the 
T lymphocytotrophic hormone (IL-2). Th1 cells mainly produce IL-12 and IFN-γ, whereas Th2 cells 
produce IL-4 and IL-10. To determine the cytokine production by PBMCs, purified M. suis antigen 
preparation was added to thawed naive and activated PBMCs and incubated for 24 h, 3 days and 
5 days in RPMI 1640 supplemented with 10 % FCS.  The activation state of PMBC was induced either 
by the combination of Phorbol Myristate Acetate (PMA; 20 mg/ml) and Ionomycin (150 ng/ml) 
(PMA/Ionomycin, Sigma-Aldrich, Switzerland) or LPS (100 ng/ml). LPS was used as a positive 
control at the concentration of 100 ng/ml, in order to stimulate the production of the following 
cytokines: IL-1, IL-6, IL-10, IL-12, TNF-α, IFN-γ. The PMA (20 mg/ml) and Inomycin (150 ng/ml) 
were used to stimulate the IL-2 and IL-4 production in PBMCs and represent the positive control for 
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IL-2 and IL-4 assays. As a negative control M. suis negative blood preparations were used. During the 
last 4 h of incubation the metalloprotease blocker brefedin (BD Bioscience, Switzerland) was added, 
in order to block the cytokine transport by the golgi apparatus. The intracellular cytokine staining was 
performed using the Cytofix/Cytoperm kit (BD Bioscience, Switzerland) according to the 
manufacturer's protocol and monoclonal antibodies. The mAbs were diluted 1:100  (Santa Cruz 
Biotechnologies, USA). 
 
4.1.1.9 Statistical analysis  
Statistical Package for the Social Sciences (SPSS 20.0.0) statistical software was used to test 
differences between groups in the PI values, number of cytokine positive cells, and 
apoptosis / necrosis rates. Differences were calculated using the unpaired Wilcoxon test and a 
p value  ≤ 0.05 was considered statistically significant.  
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4.1.2 Results 
4.1.2.1 PMBC count during experimental M. suis-infection 
To analyze the influence of M. suis on PMBCs in vivo, we determined the changes in PBMCs count 
during the M. suis induced IAP. PBMC counts were measured at different time points, starting two 
months prior to M. suis infection and continuing during the infection until euthanasia.  
Pig No 6019 was infected parenterally (intramuscularly) according to the well-established 
splenectomized M. suis pig model [41, 107] and represented the acute course of an M. suis infection 
(IAP). In contrast, pig No 6043 was infected orally (per os) and represented the chronic course of IAP. 
In both, acutely and chronically diseased pigs the number of PBMCs decreased after the infection with 
M. suis (Fig. 1). In pig No 6019 the PBMC numbers decreased continuously from 
1.3 x 104 PBMCs/mm3 blood (days post infection (DPI) 0) to 7.6 x 103 PBMCs/mm3 blood (56% of 
the initial count) on DPI 12. At DPI 12 pig No 6019 had to be euthanatized due to bad conditions (i.e. 
high fever (42 °C), hypoglycemia, lethargy, reduced food uptake, pale skin) and failure of antibiotic 
treatment. In contrast pig No 6043 showed the characteristics of a chronic course of the anemia. The 
PBMC count in pig No 6043 fluctuated: after the infection the PMBC numbers increased from 
2.1 x 104 PBMCs/mm3 blood to 2.5 x 104 PBMCs/mm3 blood on DPI 17 and then decreased to 
1 x 104 PBMCs/mm3 blood (30% of the initial count) on DPI 28 (end of the experiment).  
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Figure 1: PBMC count during the acute and chronic course of the IAP. The intravenously infected pig 
No 6019 represents the acute course of IAP (cf. acute). Pig No 6043 was infected per os and represents the 
chronic course of IAP (cf. chronic). The reference level shows PBMCs count measured under healthy conditions 
elsewhere [110]. 
 
4.1.2.2 Cytopathic effects of M. suis on PBMCs in vitro 
Apoptotic and necrotic effects of M. suis on naive and activated PBMCs was tested in vitro to 
determine whether a direct M. suis interaction plays a potential role in leukopenia. The apoptosis and 
necrosis rates were analyzed using annexin-V staining and FACS analysis. In order to test the immune 
response of PBMCs to M. suis in activated versus naive state, 100 ng/ml LPS was used to induce the 
activation state of PBMCs [108]. Apoptosis and necrosis were determined 2h, 24h, and 48h post 
M. suis stimulation to investigate early, medium, and late events. Early point apoptosis rate was 
determined after 2h of incubation. At this time point the incubation with M. suis increased apoptosis 
and decreased necrosis in naive porcine PMBCs. In contrast, M. suis incubation decreased apoptosis 
and increased necrosis in LPS activated PMBCs. 
At time point 24h (medium time point) the M. suis incubation decreased the apoptosis rate and 
increased the necrosis rate in both, naive and activated PBMCs (Fig. 2 C).  
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The late cell death rates, after 48h of co-incubation with M. suis, were characterized by decreased 
levels of apoptosis and increased levels of necrosis. The found necrosis rate was less increased in the 
naive PBMCs when compared to the activated PBMCs.   
Differences between M. suis incubated and control PMBCs were analyzed in regard to significance 
using the statistic tests described in the part “Material and Methods”. 
Overall, the medium and late apoptosis events were significantly decreased in naive PBMCs after 
M. suis incubation (24h and 48h; N = 6, p < 0.05; Fig. 2 E). In activated PMBCs all (i.e. early, 
medium and late) apoptosis events were significantly deceased (2h, 24h, 48h; N = 9, p < 0.05) 
Early and late necrosis rates of naive PBMCs upon M. suis stimulation were significantly lower 
(2h and 48h; N = 6, p < 0.05), whereas the early, medium and late necrosis rates in activated PBMCs 
were significantly higher after M. suis incubation when compared to the negative control 
(2h, 24h, 48h, N = 9, p < 0.05).  
Both, apoptosis and necrosis rates were used to calculate the overall death rates at all time points 
investigated (2h, 24h, 48h). As shown in Fig. 2D death rates in naive as well as in activated PBMCs 
were significantly lower after 24h and 48h when compared to the negative control (p < 0.05, p < 0.05).  
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Figure 2: In vitro cytopathic effect of M. suis antigen on PBMCs. M. suis induced apoptosis and necrosis 
rates of naive and LPS activated PBMCs were analyzed in vitro after 2, 24 and 48 h (A; B; C). The death rate 
was calculated from the fraction of necrotic and apoptotic cells (D). Positive control: PMBCs were incubated 
with 100 ng/ml LPS. Negative control: PMBCs were incubated with blood preparations from M. suis negative 
pigs. M. suis and LPS M. suis: Naive and LPS activated PBMCs were incubated with M. suis. 
 
4.1.2.3 Analysis of the M. suis-PMBCs interaction in infected pigs using scanning electron 
microscopy  
The PBMCs of experimentally M. suis infected pig were analyzed by SEM to visualize the effect of 
M. suis infection on PBMCs. The PBMCs were extracted from the acutely diseased pig No 6019 on 
DPI 12. At this time point crucial clinical signs (i.e. high fever (42°C), hypoglycemia, lethargy, 
reduced food uptake, pale skin) occurred and the pig had to be euthanatized. At this time point the pig 
had a bacterial blood load of 3 x 109 M. suis-cells/mL blood as determined by quantitative 
LightCycler PCR.  
PMBCs were isolated from the blood of the M. suis infected pigs according to standard methods as 
described in “Material and Methods”. The PMBC preparations were characterized by the occurrence 
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of blood clots (Fig. 2A and B). The majority of the PBMCs were involved in these blood clots, that 
consisted of erythrocytes, white blood cells, and platelets enclosed in a fibrin network (Fig. 2B). 
Single M. suis cells could not be detected on the surface of PBMCs. Between the PBMCs as well as 
attached to them, numerous microcolonies of M. suis cells of reduced size (100 nm) were observed 
(Fig. 2C). But underneath the surface of PBMCs many bleb like structures resembling M. suis 
microcolonies were present (Fig. 2D). Some of the PBMCs appeared to be necrotic with released own 
cell content surrounding them (Fig. 2E). Lesions and blebs of 200 - 800 nm covered their surface 
(Fig. 2E). Other PBMCs showed cell shrinkage and blebbing that characterizes apoptotic process 
described elsewhere (Fig. 2F).  
No blood clotting, cell debris or cell blebs were observed in the PBMC preparations from M. suis 
negative pigs. The negative PBMCs appeared as single cells (Fig. 2G) or assemblies of 2- 4 cells in 
close contact, without any fibrin fibers connecting them (Fig. 2H).  
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Figure 3: Scanning electron microscopy analysis of PBMCs from M. suis infected (A, B, C, D, E, and F) 
and non-infected (E and F) pigs. A. Overview of PBMCs from M. suis infected pig. All cells appear connected 
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to the fibrin network. Scale bar = 20 µm; B. Higher magnification of a blood clot. RBCs and PBMCs captured in 
the fibrin network were visible. Scale bar = 10 µm; C. M. suis microcolonies of juvenile M. suis cells between 
the PBMCs and attached to them were observed. Scale bar = 2 µm; D. Blebs resembling M. suis microcolonies 
underneath the surface of a PBMCs appeared frequently. Scale bar = 5 µm; E. PBMCs death resembling necrotic 
patterns was evident and in F. PBMC death characterized by apoptotic morphological changes. 
Scale bar = 5 µm (E); scale bar = 5 µm (F); G. Overview of PBMCs from M. suis negative pig. Single cells as 
well as cluster of 2 - 4 cells are present in the negative control. No fibrin network was observed in the negative 
control. Scale bar = 100 µm; H. Higher magnification of PBMCs from M. suis negative pig. The cells had the 
usual morphological characteristics. Scale bar = 2 µm. Abbreviations: AB, apoptotic bodie; AC, apoptotic cell; 
APC, antigen presenting cell; BM, bacterial microcolony; CC, cell content; Fi, fibrin fibers; NC, necrotic cell; 
PBMC, peripheral blood mononuclear cells; P, perforation; RBC, red blood cell.   
 
4.1.2.4 Quantification and microscopic analysis of M. suis positive PBMCs 
M. suis-positive PBMCs from experimentally infected pigs were stained using M. suis-specific 
antibodies [12] and quantified using FlowSight analyzer. PBMCs were extracted from the acutely 
diseased pig No 6019 on the day of euthanasia (DPI 12). The acute course of the disease was 
accompanied with a high bacteremia (3 x 109 M. suis/ml blood). The FlowSight analysis showed that 
12 % of the PMBC population was M. suis-positive (Appendix I). Since the FlowSight cytometer 
provides visual verification of the morphology of each cell analyzed and enables gating of cells from 
debris, the sorted M. suis positive PBMCs were whole, intact cells.  
Following FlowSight analysis, M.  suis positive PBMCs were sorted from M. suis negative PBMCs by 
FACS Aria III and stained with FITC-phalloidin (green), in order to visualize F-actin of PBMCs. The 
sorted cells were than analyzed by confocal laser scanning microscopy. 
Similarly to the M. suis microcolonies observed by scanning electron microscopy we found M. suis 
microcolonies attached to PBMCs and between PBMCs, clumping - PBMCs together (Fig. 4A and B). 
PBMCs in contact to M. suis microcolonies were covered by M. suis single cells (Fig. 4 B and C). 
Additionally, M. suis single cells and cell aggregations were observed inside PBMCs in every stack 
section throughout the whole volume of PBMCs (Fig. 4C). In addition some of the cells showed 
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diffuse staining that was spread all over the cell (Fig. 4A). In the negative control no M. suis specific 
signal was observed, neither as a single cell attached or inside PBMCs, nor as a microcolony attached 
to PBMCs (Fig. 4D and E).   
 
Ph.D. Thesis, Albina Sokoli 
 31  
 
Figure 4: M. suis positive PBMCs from an experimentally infected pig. PBMCs were sorted by FACS aria 
and analyzed by confocal laser scanning microscopy. PBMCs stained for actin with phalloidin-FITC (green) and 
M. suis with anti-MSG1 (red).  A. and B. An overview of M. suis positive PBMCs. Different staining patterns 
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were observed e.g. diffuse staining, clearly defined staining located to the plasma membrane, and dotted staining 
spread all over the PBMC. Scale bar = 50 µm; B. With imaris generated 3D visualization (Imaris 7.5.2) of a 
M. suis microcolony attached to two PBMCs. Scale bar = 5 µm; C. Optical section showing the inside of PBMCs 
from image B with M. suis cells inside. Scale bar = 5 µm; D. Overview of PBMCs from M. suis negative pig. 
No M. suis specific signal was detected. Scale bar = 10 µm; D. Higher magnification of PBMCs from an M. suis 
negative pig. Scale bar = 5 µm.  
 
4.1.2.5 M. suis-specific proliferation of PMBCs  
The M. suis-specific proliferation of porcine PMBCs was evaluated using an in vitro CFSE dilution 
assay. Therefore CFSE stained porcine PBMCs were stimulated with purified M. suis cells and 
analyzed after 2, 3, and 5 days respectively (Fig. 6A). Blood preparations from M. suis negative pigs 
were used as negative control. The FlowJo software was used to generate the proliferation profile 
models and to calculate the proliferation index for total PMBCs, and different PMBC fractions, 
i.e. B-lymphocytes (CD21+), T-helper cells (CD4+), and cytotoxic T-lymphocytes (CD8+; CTL). 
As depicted in Fig. 5 M. suis induced a proliferative response of all PBMC fractions, i.e. the total 
PMBC fraction, T-helper lymphocytes, CTLs, and B-lymphocytes when compared to the undivided 
CFSE population.  
In detail, after 48h M. suis stimulated T-helper lymphocytes showed a proliferation index (PI) of 1.2, 
and therefore, only a slight PI increase of 1.1. The PI of M. suis stimulated T-helper cells increased to 
1.6 after 3 days and was 1.6 fold higher than the PI of the negative control (Fig. 5 B and C). M. suis 
induced a minor but significant (p < 0.05) increase of T-helper cell proliferative response at all time 
points tested (Fig. 5 B).  
The proliferation index of M. suis stimulated CTLs (CD8+) increased significantly (p < 0.01) and 
remained elevated with PI ≥ 1.4 during the whole incubation period when compared to the negative 
control (Fig. 5 B and C).  
B-lymphocytes (CD21+) showed the highest proliferation index upon stimulation with M. suis 
(Fig. 5B). M. suis induced a ≥ 2.2 fold increase of the proliferation index of B-lymphocytes (p < 0.01).  
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A negative effect on proliferation response to M. suis in B-lymphocytes and CTL`s was observed on 
the 3rd day of incubation. At the same time point the proliferative response of T-helper cells increased.  
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Figure 5: In vitro proliferation of PBMCs upon stimulation with M. suis. CFSE stained naive PBMCs were 
stimulated with M. suis in vitro. The CFSE profiles were measured on FACS canto II. Proliferation profile 
models and indexes (PIs) were generated with the FlowJo software. A. Proliferation profile models depicting 
numbers of resulting daughter populations (peaks) 3 days post stimulation with M. suis; Calculated PIs from 
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2, 3, 5 days post stimulation with M. suis for CD21+, CD4+, and CD8+ are presented in B; Calculated fold 
increase of M. suis induced proliferative response compared to the negative control is depicted in C for 2, 3, 5 
days post M. suis stimulation. 
 
Since T-cell proliferation is dependent on the T-lymphocytotrophic hormone interleukin (IL-2) we 
quantified the number of IL-2 producing cells upon stimulation with M. suis cells in vitro. Incubation 
of PMBCs with M. suis for 24h did not increase the number of IL-2 positive T-lymphocytes. After 3 
and 5 days the incubation with M. suis the number of IL-2 producing cells moderately increased 
(Fig. 6). The M. suis induced up-regulation of IL-2 positive cells remained lower when compared to 
the PMA/Ionomycin activated PBMCs at all time points. PMA/Ionomycin was significantly (p < 0.01) 
higher than the negative control (Fig. 6). No significant differences between naive and activated 
PBMCs in IL-2 production upon M. suis stimulation could be observed.  
 
Figure 6: M. suis induced IL-2 production in 
naive and LPS-activated PBMCs. The percentage 
of IL-2 positive PBMCs upon stimulation with 
PMA/Ionomycin (positive control) and M. suis is 
shown. The intracellular IL-2 was quantified with 
FACS canto II. 
 
 
 
4.1.2.6 Altered cytokine environment and Th1/Th2 immune response 
Together with other factors e.g. strength of T-lymphocytes stimulation and pathogen associated 
molecular patterns (PAMPs), the cytokine environment determines the T-helper subset development. 
To get insights into the development of T-helper cell (Th1 and Th2), we stimulated naive and LPS 
activated PBMCs with M. suis in vitro. The number of cells positive for intracellular Th1 and Th2 
promoting cytokines was quantified by flow cytometry. Cytokines favoring Th1 immune response are 
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IFN-γ and IL-12.  Th2 immune response beneficial cytokines are IL-4 and IL-10. T-regulatory cells 
also produce the latter to suppress the immune response of other immune cells.  
After 1 day of incubation M. suis induced an increase of naive PBMCs positive for all four cytokines 
tested. Fold increase of Th1 and Th2 cytokine positive PBMCs was ≥ 1.2 higher compared to the 
negative control (Fig. 7A and B). When PBMCs were activated with LPS or PMA/Ionomycin, the 
number of cytokine positive PBMCs upon stimulation with M. suis remained lower than the number of 
naive PBMCs stimulated with M. suis (Fig. 7A and B).  
After 3 days of incubation, IL-10 positive PBMCs dominated: naive PMBCs as well as activated 
PMBCs reached compared to negative control a 4 and 2.9 (Fig. 7A) fold increase of IL-10 expression, 
respectively (Fig. 7A, 7B).  
From time point 3 days to time point 5 days, the expression of Th1 and Th2 favoring cytokines IFN-γ, 
IL-4 and IL-10 decreased in naive PMBCs.  Nevertheless, the number of IFN-γ positive cells was 
higher in comparison to the number of IL-4 producing cells, even on the 5th day.  
Similar IL-4 and IL-10 expression patterns were observed upon stimulation with M. suis antigen in 
LPS activated PBMCs. However, IL-4 and IL-10 expression was lower in the activated PMBCs 
compared to the naive cells.   Furthermore, IFN-γ expression decreased and IL-12 expression 
increased in LPS activated PBMCs. 
 
 
Figure 7: Th1 and Th2 cytokine profiles. Values show the calculated fold increase of cytokine production 
upon stimulation with M. suis compared to negative blood preparation. A. Cytokine profiles induced by M. suis 
antigen in naive PBMCs. B. Cytokine profiles induced by M. suis in activated PBMCs. PBMCs tested for IL-4 
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production were activated with PMA/Ionomycin. The activation of PBMCs tested for IL-10, IL-12, and IFN-γ 
was induced with LPS.  
 
4.1.2.7 In vitro upregulation of proinflammatory cytokines 
To test the influence of M. suis on proinflammatory cytokine production naive and LPS activated 
PBMCs were cultivated with M. suis antigen. After 1, 3 and 5 days the number of TNF-α, IL-6 and 
IL-1 positive cells was determined by flow cytometry. The results are illustrated in Fig. 8.  
Compared to the negative control M. suis induced a significant upregulation of TNF-α, IL-6 and IL-1 
(p < 0.05; p < 0.05; p < 0.05). IL-1upregulation upon M. suis stimulation could be observed from the 
first day of cultivation, whereas IL-6 and TNF-α positive cells increased after 3 days of incubation. 
After 3 days of incubation, M. suis induced upregulation of TNF-α positive PBMCs (naive and 
activated) was even higher than LPS (positive control) induced upregulation. After 5 days the number 
of TNF-α, IL-6 and IL-1 positive cells were higher in the activated cell fraction when compared to the 
naive cell fraction.  
 
 
Figure 8: Percentage of proinflammatory cytokine positive PBMCs. M. suis induced increase in IL-1, IL-6, 
and TNF-α positive PBMC number compared to negative control. A. IL-1 production in naive and activated 
PBMCs upon stimulation with M. suis. M. suis induced increase in number of IL-1 positive naive and activated 
PBMCs. The number of activated PBMCs positive for IL-1 was higher than the number of naive PBMCs 
positive for IL-1. B. IL-6 production in naive and activated PBMCs upon stimulation with M. suis. The number 
of naive PBMCs positive for IL-6 was higher than the number of activated PBMCs in the first 3 days of 
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incubation. The opposite was observed after 5 days of incubation. C. M. suis induced production of TNF-α in 
naive and activated PBMCs. M. suis induced increase in number of TNF-α positive naive and activated PBMCs. 
The number of TNF-α positive activated PBMCs was higher than the number of naive PBMCs positive for 
TNF-α.   
 
 
 
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  
Ph.D. Thesis, Albina Sokoli 
 39  
4.1.3 Discussion 
M. suis has the ability to establish a lifelong persistent infection [13]. However, there are only limited 
studies to investigate the underlying persistence mechanisms. One former study provided strong 
evidence to suggest that M. suis infections suppress the T-lymphocyte blastogenic responses by 
inducing an alteration of T-lymphocyte activities. Additionally it was reported that M. suis induces a 
polyclonal B lymphocyte activation and the production of autoreactive antibodies of the IgM and IgG 
type [36, 39]. This misdirected immune regulation (i.e. immune modulation) helps M. suis to avoid 
elimination and to establish persistent infections in an immunologically hostile environment. 
However, analysis of immunomodulatory activities of M. suis in experimental animals is difficult due 
to the extraordinary complexity of the system. For this reason detailed studies focusing on M. suis 
effects on single components of immune system are missing so far. The present study was undertaken 
to analyze the interaction of M. suis with PBMCs, to identify immune components targeted by M. suis 
in order to clarify mechanisms that are responsible for the M. suis induced modulation of host immune 
responsiveness. 
To obtain first insights we determined the PBMC counts during experimental infection. The acutely 
diseased pig presented a mild leukopenia whereas the chronically diseased only showed a slight 
decrease of PBMC count [111, 112]. Both, leukopenia and leukocytosis were reported in M. suis 
infected animals [34, 35, 113]. Interestingly, leukopenia was described as a symptom in human 
hemotrophic mycoplasma infections, i.e. in one case of human “eperythrozoonosis” [114] and in an 
infection with the new hemotrophic bacterial species Candidatus M. haemohominis [24]. Leukopenia 
is a common response to several infections with viruses but also bacteria like Mycoplasma fermentans 
that cause immune modulation of host [115-117]. M. fermentans - derived membrane lipoprotein 
LAMPf was shown to induce leukopenia in vivo [115] and cell death of thymocytes in vitro [118]. 
The decrease in PBMCs count upon infection with M. suis could be due to an direct cytopathic effect 
of M. suis components on PBMCs or an indirect effect via immunopathology induced by M. suis 
infection. Direct cytopathic effects could involve apoptotic or necrotic cell death. Previous studies 
have shown that the endonuclease activity of various mycoplasmas can result in an increased 
sensitivity of PBMCs to apoptosis induction [119]. In our study, we found evidence for a direct 
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cytopathic effect of M. suis on PBMCs via apoptosis and necrosis only in the first 2 h of incubation. 
At this time point the M. suis induced PBMC death rate (consisting of apoptosis and necrosis rate) was 
distinctly higher than the negative control. However, longer incubation of PBMCs with M. suis 
obviously had an adverse effect on the PBMC death rate: no cytopathic effect of M. suis on PBMCs 
was observed, the total cell death rate rather decreased than increased. Especially the number of 
apoptotic events was decreased when compared to the controls. Therefore, it could be assumed that 
M. suis may contribute to survival of PBMCs in vitro and may act as a kind of prosurvival factor by 
alleviating proapoptotic signals as it was described for other mycoplasmas [119]. Further studies are 
necessary to analyze whether the decreased cell death rate an effect of the specific situation in the 
hemotrophic M. suis research is, i.e. M. suis do not proliferate in vitro and, therefore, increasing 
bacterial loads or the viability of M. suis in infected animals might account in vivo for a possible 
cytopathic effect on PBMCs, that we observed in experimentally infected pigs. This correlation 
between viability/pathogen replication and the induction of leukopenia was reported for e.g. infections 
with the human cytomegalovirus infections. Our SEM analyses supported this hypothesis, since 
PBMCs from M. suis infected pig displayed morphological patterns which were highly indicative for 
necrotic and apoptotic processes, i.e. the release of own cell content surrounding the cells, surface 
localized lesions and blebs of 200 - 800 µm as well as cell shrinkage and blebbing [119, 120]. Further 
studies are required to analyze whether M. suis has a cytopathic effect on PBMCs. In particular, 
in vivo analysis of the apoptotic and necrotic M. suis effects on PBMCs in correlation to the bacterial 
load profiles would provide further insights. Furthermore, in vitro experiments are needed to assess 
the potential relationship between M. suis and PBMC apoptosis or to determine putative specific host 
cell signaling pathways, which are modulated by M. suis.  
Interestingly, we observed that majority of PBMCs from M. suis infected pigs was embedded in blood 
clot.  The found blood clot formations could also contribute to the observed leukopenia. The clotted 
PBMCs were interconnected via fibrin network and also connected with M. suis infected erythrocytes. 
These clots were similar to blood clots observed sealing the injuries of the endothelium induced by 
M. suis infection [121]. PBMCs caught by fibrin networks of blood clots were not available as single 
cells for hematologic measurement therefore the coagulopathy might explain the decreased number of 
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PBMCs in M. suis infection. A previous study has shown that thrombocytopenia induced by M. suis 
infection was attributed to intravascular coagulation and subsequent consumption coagulopathy [106]. 
Moreover, the endothelium could be involved in the development of leukopenia during an M. suis 
infection: recently we have demonstrated that M. suis infections induce activation and destruction of 
the endothelium [121]. From other studies it is well known that an activated endothelium recruits as 
well as translocates PBMCs from blood vessels into the inflamed tissue [122]. The possible role of the 
endothelium in the development of leukopenia during an M. suis infection remains to be clarified by 
e.g. histological analysis of tissue from M. suis infected pigs.  
M. suis is capable of attaching and invading erythrocytes and endothelial cells [18, 121]. In this study, 
we wanted to determine whether PBMCs are also a target for attachment and invasion. For other 
pathogens invasion of PBMCs is well known to contribute to the misdirected immune response and to 
the persistence of infections [123]. Firstly, we demonstrated by SEM that M. suis cells were attached 
to PBMCs from infected pigs. However, in contrast to infected erythrocytes, we could not find single 
and regular shaped M. suis cells but rather M. suis microcolonies attached to PBMCs. These 
microcolonies consisted of irregular M. suis cells of reduced size resembling juvenile and 
nanotransformed cells described on infected erythrocytes and in M. suis cultures, respectively [36, 45, 
124]. Secondly, frequently observed blebs underneath the surface of PBMCs resembled intracellular 
localized M. suis microcolonies. Probably the PBMC surface with its numerous surface extensions 
made the recognition and visual distinction of single M. suis cells difficult, especially in case of 
juvenile forms of M. suis. Immunofluorescence labeling and microscopic analysis confirm these 
findings. M. suis microcolonies were found in close contact to PBMCs. CSLM optical sections clearly 
demonstrated that these PBMCs with attached M. suis microcolonies contained intracellular M. suis 
single cells and cell clusters. Attachment to and invasion of PBMCs has also been reported in M. bovis 
[119]. Importantly, these M. bovis cells attaching and invading the PBMCs also appeared as clumps, 
which might resemble a kind of microcolony.   
The non-fractioned PBMC population analyzed consists of different cell types e.g. phagocytic host 
cells (i.e. monocytes and dendritic cells), therefore the presence of both Mycoplasma species (M. suis 
and M. bovis) inside the PBMCs might result from an active bacterial process or internalization via 
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phagocytosis. Therefore, further analyses are required to confirm an invasion process or a phagocytic 
fusion of M. suis with PBMCs. Immunogold electron microscopic analysis will give more insights into 
the possible mechanisms responsible for invasion or fusion of M. suis with PBMCs [125]. 
Furthermore, our results raise the important question in regards to the involvement of the M. suis 
adhesion proteins MSG1 and α-enolase in the attachment to and invasion in PBMCs [12, 45]. For 
M. bovis the proteins responsible for the attachment and invasion in PBMCs were not identified so far, 
and for M. suis, PBMC adhesion proteins remain to be determined.  
M. suis infections resulted in T-lymphocyte suppression and misdirected immune responses [36] 
supporting the establishment of persistent infections. Our in vitro experiments revealed an alteration of 
blastogenic response of B- and T-lymphocytes in the early phase of M.  suis-PBMC interaction. 
M. suis antigens induced a high proliferation of naive B-lymphocytes after 2 days and at the same time 
no significant up-regulation of T-helper cells indicating a T-helper cell independent B-lymphocyte 
polyclonal activation. This is consistent with previous finding i.e. that M. suis induced abrupt decrease 
of specific immune response was associated with an abrupt increase of autoreactive IgG antibodies 
[43]. Both facts support the hypothesis that M. suis must have a B-lymphocyte mitogen that is able to 
induce the polyclonal activation and proliferation of naive B-lymphocyte without previous 
sensitization of lymphocytes [126].  
In parallel, the T-lymphocyte proliferative response to M. suis was only moderately increased. This 
result is in line with the report concerning altered T-lymphocyte blastogenic response [36]. 
Furthermore we found strong evidence for a T-regulatory cell activation and the suppressive effect of 
T-regulatory cells on T-helper cells, i.e. (1) the observed proliferation profiles of CD4-, CD8-, and 
CD21-positive cells were typically characterized by an inversely proportional course of the 
proliferation level of CD4-positive cells to the proliferation levels of CD21- and CD8-positive cells. 
This inverse proliferation relationship of CD4- positive cells with CD21-, and CD8-positive cells is 
highly indicative for T-regulatory cell activation and an increased suppressive effect of T-regulatory 
cells (CD4+ CD25+ foxp3+) on T-helper cells.  (2) IL-2 and IL-10 expression patterns were also 
highly indicative for a T-regulatory cell activation and an increased suppressive effect of T regulatory 
cells. Immune suppressive and immunomodulative T-regulatory cells suppress T-helper cells and are 
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important factors during immune responses particularly with regard to autoimmune processes, which 
are main pathogenic features during M. suis infections. T-helper cell suppression by T-regulatory cells 
via IL-2 consumption, induction of apoptosis and IL-10 production has an important role in preventing 
autoimmunity and immunopathology [127, 128]. The T-regulatory cell activation is characterized by 
increased IL-2, and IL-10 levels and by the suppressive effect on other PBMCs [46, 89, 127, 128]. In 
M. suis, the number of IL-2 positive T-lymphocytes increased after 3 days, and most probably as a 
consequence thereof the proliferative response of naive T-regulatory cells (CD4+) also increased. 
However the increase was only minor [1]. The M. suis induced IL-10 positive T-regulatory cells also 
reached the highest peak on day 3 and henceforth, the proliferative response of CD4+ (most probably 
of T-helper type) decreased on day 5. Further analysis are required to confirm the suppressive effect of 
T-regulatory cells on T-helper cells upon stimulation with M. suis and to determine the role of 
T-regulatory cells during autoimmune processes in M. suis infected pigs [89].  
Analysis of the cytokine patterns gave valuable information about the Th1/Th2 balance during an 
M. suis infection. Interestingly, the number of IL-10 positive cells decreased on day 5 and no increase 
of IL-4 positive cells was observed, which indicates that the anticipated Th1/Th2 shift does not occur. 
Both types of immune response Th1 as well as Th2 seemed to be active in the early phase of the 
in vitro interaction. This result is in accordance to the outcome of a previous immunization study by 
Hoelzle and co-workers [41]; the immunization of pigs with recombinant MSG1 resulted in 
production of IgG1 and IgG2. However, the immunization study of Hoelzle and co-workers also 
documented a Th2 dominated immune response if the pigs were vaccinated with Escherichia coli 
transformants expressing MSG1. And this Th2 dominance was obviously correlated to an increased 
protection efficacy (i.e. fatality of IAP). According to elevated number of IFN-γ-positive cells 
compared to IL-4-positive cells, this study suggested a predominance of the Th1 response in the early 
phase of disease. Therefore, M. suis antigens other than MSG1 must be responsible for the induction 
of Th1 type of the immune response. In addition, an overshooting Th1 immune response leads to 
immunopathological features observed in M. suis infections e.g. disseminated tissue damage and 
autoimmunity [13, 88, 121]. However, IL-4 and IFN-γ-positive cell number decreased on day 5 of the 
in vitro stimulation with M. suis. It is well known, that the acquired immune response needs at least 4 
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days to develop and is characterized by either Th1 (IFN-γ, IL-12) or Th2 (IL-4) positive cell 
proliferation [78]. Therefore the in vitro induced drop in the IL-4, IL-12, and IFN-γ positive cells after 
5 days might represent a possible suppression mechanism of cell mediated specific immune response 
in M. suis infection. Follow up studies are needed to confirm this outcome in vivo.  
A detailed look at the cytokine expression levels during the interaction of M. suis with PBMC in vitro 
provided further insights into some pathogenic features during M. suis infections. The decrease of 
IL-12 positive cells upon M. suis stimulation represents a potential mechanism of immune response 
impairment, since IL-12 is essential for initial bacterial control in infections and IL-12R deficient 
humans were shown to be highly susceptible to intracellular pathogens [129, 130]. IL-12 is produced 
by antigen presenting cells (APCs) and has been shown that, in contrast to mouse model, in humans 
IL-10 affects APCs instead of Th1 cells [131]. Interestingly, pigs have the same mechanism as in 
humans, the in vitro increase of IL-10 positive cells lead to decrease of IL-12 positive APCs, thereby 
affecting the Th1 immune response indirectly.  
M. suis antigen induced an increase of the following proinflammatory cytokines: TNF-α, IL-1, and 
IL-6. These proinflammatory cytokines enhance the T-lymphocytes response [132]. Increased levels 
of these multifunctional proinflammatory cytokines were associated with the immunopathology in 
different infectious disease e.g. dengue fever, meningococcal septic shock and different mycoplasma 
induced diseases [133-136]. In M. suis infected pigs the acute disease is characterized amongst other 
clinical signs by fever, immunopathology and hemorrhagic diathesis. The high load of M. suis in the 
blood most probably leads to in vivo overproduction of proinflammatory cytokines with amplification 
of inflammatory response of Th1 type. The amplified immune response with enhanced 
proinflammatory environment leads to activation of APCs and bystander activation of self-reactive 
lymphocytes like the previously reported production of IgG-autoantibodies to host actin [137]. The 
proinflammatory environment, especially TNF-α and IL-1, increase leads to observed endothelial 
activation, widespread damage, and vascular occlusion in M. suis infected pigs [106, 121]. 
This study provides new puzzle pieces that shed light on the M. suis persistence strategy and the 
M. suis induced pathology.  
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The found coagulopathy implicates leukopenia, which represents immune system impairment and 
supports the persistence of the agent. Even in the early phase of interaction M. suis induces T-helper 
cell inhibition, thereby preventing the generation of M  suis specific cellular immune responses. The 
inhibition of T-helper cell activation occurs most probably due to M. suis induced increase of IL-10, 
indicating the activation of T-regulatory cells. During exposure to M. suis a rise in the level of IL-10 
was accompanied by parallel decline in the production of IL-12, indicating an attenuated phagocytic 
function of macrophages.  
The T-helper cell independent B-lymphocyte polyclonal activation by M. suis leads to the production 
of autoreactive antibodies, resulting in the autoimmunity.  
The elevated levels of proinflammatory cytokines upon M. suis stimulation lead to the increased 
activation of innate immunity components and dysfunctional activation of the endothelium. Both 
conditions contribute to the systemic inflammation and immunopathology. Furthermore, the study 
provides first evidence that M. suis was found attached not only to erythrocytes and free in plasma but 
also in close association with PBMCs as microcolonies, which could potentially aid transport of 
M. suis to other tissues within the host. In summary, clarification of immune mechanisms as well as 
host cell tropism and persistence mechanisms will help us in future to develop new strategies for the 
control and prevention of this economically important disease. 
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4.2 Objective 2. The role of endothelial cell in hemorrhagic diathesis induced by M. suis 
infection 
4.2.1 Manuscript: “Mycoplasma suis infection results endothelial cell damage and activation: 
new insight into the cell tropism and pathogenicity of hemotrophic mycoplasma”. 
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Abstract 
Hemotrophic mycoplasmas (HM) are highly specialized red blood cell parasites that cause infectious 
anemia in a variety of mammals, including humans. To date, no in vitro cultivation systems for HM 
have been available, resulting in relatively little information about the pathogenesis of HM infection. 
In pigs, Mycoplasma suis-induced infectious anemia is associated with hemorrhagic diathesis, and 
coagulation dysfunction. However, intravasal coagulation and subsequent consumption coagulopathy 
can only partly explain the sequence of events leading to hemorrhagic diathesis manifesting as 
cyanosis, petechial bleeding, and ecchymosis, and to disseminated coagulation. The involvement of 
endothelial activation and damage in M. suis-associated pathogenesis was investigated using light and 
electron microscopy, immunohistochemistry, and cell sorting. M. suis interacted directly with 
endothelial cells in vitro and in vivo. Endothelial activation, widespread endothelial damage, and 
adherence of red blood cells to the endothelium were evident in M. suis-infected pigs. These 
alterations of the endothelium were accompanied by hemorrhage, intravascular coagulation, vascular 
occlusion, and massive morphological changes within the parenchyma. M. suis biofilm-like 
microcolonies formed on the surface of endothelial cells, and may represent a putative persistence 
mechanism of M. suis. In vitro analysis demonstrated that M. suis interacted with the endothelial 
cytoskeletal protein actin, and induced actin condensation and activation of endothelial cells, as 
determined by the up-regulation of ICAM, PECAM, E-selectin, and P-selectin. These findings 
demonstrate an additional cell tropism of HM for endothelial cells and suggest that M. suis interferes 
with the protective function of the endothelium, resulting in hemorrhagic diathesis.  
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Introduction 
Hemotrophic mycoplasma (HM) is a global etiological agent of infectious anemia in a variety of 
animals. HM is a small erythrocytic parasite that adheres to and invades red blood cells (RBCs), which 
are the exclusive host cell of HM [1-3]. To date, no in vitro cultivation system for HM has been 
established. In the past few years, reports of zoonotic human HM infections have increased markedly. 
Strains of Mycoplasma suis, M. haemofelis and M. ovis have been isolated from humans [4-6]. 
Additionally a novel HM species, termed Candidatus M. haemohominis, was recently reported in a 
human subject and was associated with clinical symptoms of pyrexia and hemolytic anemia [7]. 
In pigs, acute M. suis infection (infectious anemia in pigs, or IAP) manifests as hemolytic anemia and 
hemorrhagic diathesis accompanied by immune modulation and coagulation dysfunction due to 
intravasal coagulation and subsequent consumption coagulopathy [8-13]. However, disseminated 
intravascular coagulation cannot fully account for the clinical signs of acute M. suis infection, e.g. 
cyanosis, petechial bleeding, and ecchymosis. One possibility is that the endothelial cells (ECs) of the 
vasculature are involved in the pathogenesis of IAP. Electron microscopic studies of RBCs from 
experimentally-infected pigs revealed massive morphological changes as well as strong agglutination 
of parasitized and non-parasitized cells. Blood clotting in these animals was attributed to the formation 
of cold and warm autoreactive IgM and IgG antibodies directed against the RBC surface and to an 
acute phase response of the immune system [8, 13, 14].  
To date, several pathogenic bacteria, including M. mycoides subsp. mycoides, M. gallisepticum, 
M.  neurolyticum, Bartonella bacilliformis, Rickettsia conorii and Bacillus anthracis, have been 
described that target and damage the endothelial barrier, or interact closely with EC, triggering 
inflammatory responses and coagulation processes. In this manner, they are able to interfere with the 
protective function of ECs through a variety of mechanisms, including invasion and toxin induced 
endothelial damage, that latter of which could induce hemorrhagic diathesis [15-20]. 
Based on current evidence, RBCs serve as the exclusive target and host cell of M. suis. The goal of the 
current study was to elucidate potential interactions between M. suis and ECs both in vivo and in vitro. 
Our hypothesis is that the interaction of M. suis with ECs, via either adhesion and/or activation, leads 
to an activated EC phenotype, thereby mediating damage to the vascular endothelium and activation of 
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pro-inflammatory and inflammatory cascades. These direct and indirect interactions induce a systemic 
immune response resulting in endothelial pathophysiology. We demonstrated that M. suis closely 
interacts with ECs in vivo and in vitro, resulting in endothelial activation and destruction. M. suis 
infection led to endothelial damage, the induction of pro-inflammatory and inflammatory cascades, 
and immunopathology. 
 
Materials and Methods  
Experimental infections  
Experimental M. suis infection was performed as described previously [21-23] in accordance with 
Swiss legislation for animal welfare (Veterinary Office of Zurich, Switzerland; approval 55/2007; 
68/2009). Briefly, M. suis-negative piglets (n = 10) underwent splenectomy and then six of them were 
infected with an intramuscular inoculation of 2 ml of M. suis-containing blood 
(strain 3806; 1 × 108 M. suis/ml blood [1]. Pigs were scored daily for the following parameters: 
feeding behavior, body temperature, and clinical signs, as previously described [24]. Briefly, a score 
of 1 was given for each occurrence of reduced food uptake, fever (>  40°C), lethargy, and pale skin/ear 
necrosis. Individual scores were then summed to arrive at an overall score for each animal. When a 
score of 4 was reached (clinical attack), pigs were treated with tetracycline (40 mg/kg body weight) 
and glucose (35 g/L drinking water), or euthanized. M. suis-negative pigs were monitored similarly.  
 
Cell culture  
Primary porcine aortic endothelial cells (PAEC; European Collection of Cell Cultures, Salisbury, UK) 
were used for the in vitro adhesion assays. The immortalized porcine aortic endothelial cell line 
PEDSV.15 was used for in vitro activation [25]. PAECs were cultured in Porcine Endothelial Growth 
Medium (CellMade, Archamps, France) containing penicillin (100 U/mL) and streptomycin 
(100 mg/mL). PAECs between passages three and six were seeded on cover slips in a 24-well tissue 
culture plate.  
PEDSV.15 were maintained in DMEM supplemented with 10 % FCS, 1 mM sodium pyruvate, 
1 mM L-glutamine, non-essential amino acids, and 20 mM HEPES (all from Biochrom, Berlin, 
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Germany) [26]. PEDSV.15 cell culture assays were performed at 37 °C and 5 % CO2 in 1.5 ml of 
DMEM in 12-well tissue culture plates. 
 
Purification of M. suis 
M. suis was purified from the plasma of infected pigs as described previously, with slight 
modifications [22, 23]. Briefly, sodium citrate anti-coagulated blood was subjected to centrifugation 
for 5 min at 300 × g to sediment the erythrocytes. Plasma was removed and subjected to centrifugation 
at 20000 × g for 1 h at room temperature (RT) (Hettich Rotixa/AP; Hettich, Tuttlingen, Germany). 
The resulting pellet was washed twice and then resuspended in phosphate buffered saline 
(PBS, Biochrom). M. suis was quantified by LightCycler (LC) PCR analysis [27]. As a negative 
control, blood from non-infected pigs was prepared using the same procedure (negative control 
preparation).  
 
Harvesting of blood vessels and parenchyma (heart and liver 
Blood vessels (abdominal aorta and veins) and parenchyma (heart and liver) were collected from 
euthanized M. suis-infected and control pigs to examine the effect of M. suis on the ECs. Blood 
vessels and parenchyma were immediately fixed in 4 % phosphate-buffered formaldehyde (FA) for 
24 h. Other tissues (lymph nodes, liver, kidney, gut, pancreas, and spleen) were immediately fixed in 
methanol/glacial acid (2:1 for 24 h) or in Bouin’s fluid, and then embedded in paraffin according to 
standard procedures. 
 
Light microscopy and scanning electron microscopy of aortic vessels  
FA-fixed blood vessels and parenchyma were post-fixed in 2.5 % phosphate-buffered glutaraldehyde 
(GA) for 24 h and then stored in 0.1 M cacodylate buffer until further processing. Strips 2 cm in length 
(long axis) of the fixed blood vessels were cut in half for macroscopic documentation under a Leica 
Z16 APO light microscope (Leica Microsystems, Heerbrugg, Switzerland). After microscopy, tissues 
were post-fixed for 1 h at RT in 1 % osmium tetroxide (Fluka Chemie, Buchs, Switzerland) in 
0.1 M cacodylate buffer, dehydrated through a graded ethanol series, and then subjected to critical 
Ph.D. Thesis, Albina Sokoli 
 51  
point drying (BAL-TEC CPD 030, Critical Point Dryer, Balzers, Liechtenstein). Finally, the samples 
were sputter-coated with 12 nm of platinum using the BAL-TEC MED 020 coating system, mounted 
on an aluminum stub, and then analyzed on a Zeiss Supra 50 VP (Oberkochen, Germany) scanning 
electron microscope.  
 
Immunohistochemical staining of aortic vessels and parenchyma 
For immunohistochemistry, the fixed and paraffin embedded tissues were cut into sections 
(5 µm thick) and mounted on Superfrost® glass slides. After deparaffinization and antigen retrieval in 
a microwave oven in 10 mM sodium citrate buffer at pH 6.0 (3 × 5 min at 700 W), sections were 
subjected to immunohistochemistry using an M. suis-specific rabbit polyclonal antibody directed 
against α-enolase (1:200 in PBS) [28]. Briefly, sections were treated with 1 % hydrogen peroxide in 
double-distilled water for 10 min at RT to block endogenous peroxidase activity followed by 10 % 
normal goat serum (Dako, Hamburg, Germany) for 30 min at RT to prevent non-specific protein 
binding. This was followed by incubation with the primary antibody at 5 °C overnight in a humid 
chamber. The next day, sections were incubated with biotinylated goat anti-rabbit IgG 
(1:100 in PBS; Dako) for 30 min at RT. Antibodies were detected using a Strept-ABC kit (Dako) 
according to manufacturer’s instructions. Each incubation step was followed by 3 × 5-min rinses 
with PBS. The reaction product was visualized with 3,3’-diaminobenzidine-hydrogen-peroxide 
reagent (DAB) (Biotrend Chemicals, Köln, Germany). Finally, sections were counterstained with 
Mayer’s hematoxylin, dehydrated, cleared with xylene, and then mounted in Entellan (Merck, 
Darmstadt, Germany). The samples were analyzed using a brightfield light microscope (DMRBE, 
Leica, Bensheim, Germany) equipped with a video camera (ProgRes, Kontron Instruments, Watford, 
UK). Immunohistochemical controls were performed by (1) replacing the primary antibody with non-
immune serum, (2) omitting the secondary antibody, and finally (3) incubation with DAB solution 
alone to ensure specificity of staining.  
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Transmission electron microscopy of aortic vessels and parenchyma   
Formaldehyde-fixed blood vessels and parenchyma were cut into 1–2 mm segments and post-fixed in 
2.5 % phosphate buffered GA solution for 24 h. Samples were washed in 0.05 M cacodylate buffer 
and stored at 4 °C until further processing. Following post fixation in 2 % osmium tetroxide in 
cacodylate buffer, sections were washed once in 0.05 M cacodylate buffer. Samples were dehydrated 
in increasing concentrations of ethanol (70–100 %) and then infiltrated by increasing concentrations 
(33 and 50 %) of Epon 812 (Fluka Chemie) in ethanol (100%) for 1 h each. After incubation in a 
mixture of 75% Epon and 25% ethanol overnight, samples were infiltrated with fresh pure Epon for 
2-3 h. Specimens were embedded in fresh Epon in flat silicone rubber molds and hardened for 12 h at 
60 °C. After preparation of ultrathin sections using an Ultracut E microtome (Reichert-Jung, Vienna, 
Austria), sections were placed on copper grids (Plano GmbH, Wetzlar, Germany), contrasted 
consecutively with 4% uranyl acetate (Fluka Chemie) and lead citrate as described previously 
(Reynold 1963), and then analyzed with a Philips CM100 transmission electron microscope equipped 
with a Gatan Orius CCD camera (Gatan, Munich, Germany).  
 
Immunogold staining of M. suis in aortic tissue 
FA-fixed blood vessels were cut into 5–8 mm segments, equilibrated in 30 % sucrose and then 
embedded in tissue-Tek (Sakura Finetek, Staufen, Germany) at -40 °C. Horizontal segments 
(40 µm thick) were sectioned using a Kryostat HYRAX C 60 (Zeiss, Jena, Germany) to view the 
subcellular matrix underneath the endothelium. Sections were permeabilized with 0.2 % Triton X-100 
(Sigma-Aldrich, Buchs, Switzerland) for 1 h at RT and then incubated for 24 h with a monoclonal 
antibody against the M. suis surface protein, MSG1 (10 µg/mL). Sections were then washed three 
times for 20 min each with PBS and then incubated with 1.2 nm colloidal gold particles conjugated to 
goat anti-mouse IgG (1:1000) [29] for 1 h at RT. Sections were washed three times for 15 min each 
with PBS and then post-fixed for 30 minutes in 2.5 % GA. After GA fixation, sections were washed 
twice with distilled water for 20 min. Silver enhancement was performed using the silver enhancement 
kit (BBI International, Cardiff, United Kingdom). After post-fixation with 2 % osmium tetroxide in 
PBS, sections were prepared for EM as described for aortic vessels and parenchyma.  
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In vitro adhesion of M. suis to PAECs  
PAECs on cover slips were incubated with purified M. suis (1 × 104 M. suis/mL; 100 µL/well) or the 
negative control purification preparation (100 µL/well) for different time periods (5 min to 5 days). 
After washing twice with PBS, cells were fixed in 2.5 % phosphate buffered FA for 2 h at 4 °C. After 
washing again with PBS, PAECs were permeabilized with 0.2% Triton X-100 (Sigma-Aldrich) for 
2 min at RT. Cells were washed with PBS and non-reacted aldehydes were blocked with 
0.1 M glycine (Carl Roth, Karlsruhe, Germany) in PBS for 20 min. Non-specific binding of antibodies 
was reduced by incubation of samples in blocking buffer (3 % BSA in PBS) for 30 min. Adhesion of 
M. suis to PAECs was visualized by staining with rabbit anti-HspA1 serum (1:100) [30] for 1 h 
followed by TRITC-conjugated goat anti-rabbit IgG (Sigma-Aldrich) for 1 h. Filamentous actin in the 
PAECs was visualized using FITC-phalloidin (1:80 in PBS; Invitrogen, Basel, Switzerland) and the 
nucleus was counterstained with DAPI (250 ng/mL). The samples were analyzed on a Leica SP2 
confocal laser scanning microscope (CLSM, Leica Microsystems). 
 
FACS analysis of adhesion molecule expression upon interaction with M. suis 
To analyze the activation of endothelial cells by M. suis, PEDSV.15 cells at 60 % confluence were 
incubated in duplicate with purified M. suis (1 × 104 cells /mL; 0.5 mL in PBS) or the negative control 
purification preparation. Cells were harvested and fixed in 2.5 % FA after 2 h and 4 h for the analysis 
of E (CD62E)- and P (CD62P)-selectin expression, respectively, and after 24 h, for the analysis of 
intercellular adhesion molecule 1 (ICAM-1; CD54) and platelet endothelial cell adhesion molecule 1 
(PECAM-1; CD31) expression [31-33]. These time points corresponded to the maximum up-
regulation of activation markers determined with the positive control, i.e. tumor necrosis factor a 
(TNF-α) and lipopolysaccharide (LPS; Sigma). Fixed cells were incubated with 100 µL of blocking 
buffer (10% BSA in PBS) for 30 min at RT, followed by specific antibodies directed against ICAM-1 
(clone 19C7; a kind gift from D. Haskard, Imperial College London, UK), PECAM-1 (LCI-4; AbD 
Serotec, Oxford, UK), P-selectin (clone 12C5; D. Haskard) and E-selectin (clone 1.2B6; AbD Serotec) 
as previously described [34, 35]. FITC-conjugated goat anti-mouse IgG (1:1000; Sigma-Aldrich) was 
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used as a secondary antibody. Samples were analyzed using a FACSCanto II cell sorting system (BD 
Biosciences, Allschwil, Switzerland). Experiments were performed three times.  
SPSS statistical software was used to test differences in the expression of cell surface markers between 
groups. Differences were calculated using the unpaired Wilcoxon test and a P value ≤ 0.05 was 
considered statistically significant.  
 
Results 
Endothelial cell alteration and activation in M. suis-infected pigs 
Microscopic analysis of the vascular endothelium of M. suis-infected pigs revealed marked alterations 
of the luminal surface of the abdominal aortic vessel, which appeared rough and covered in reddish 
spots (Appendix IA). These red dots indicated aggregated blood cells and perforation of the vessel 
walls. By comparison, the endothelial surface of the abdominal aortic vessel in healthy pigs exhibited 
a smooth and even surface structure (Appendix IB). Histological and immunohistochemical analysis 
of the organs of M. suis-infected pigs (gut tissue, heart, lung, liver, lymph nodes, and spleen) revealed 
clear evidence of hemorrhage in the tissues and massive alterations in tissue structure, particularly in 
the vascular tissue. Infection with M. suis also resulted in injury to the ECs lining the post-capillary 
venules and small veins. As shown in Figure 1, early signs of degeneration, i.e. massive cellular 
protrusions into the vessel lumen, were accompanied by acute cytoplasmic swelling. Subsequently, 
desquamation, necrosis and detachment of ECs from the underlying basement membrane were 
observed, resulting in progressive cellular denudation of the luminal surface. Numerous M. suis cells 
could be detected within the detached endothelium (Figure 1).  
Scanning electron microscopy (SEM) of the aortic vessel of M. suis-infected pigs revealed areas of 
endothelial denudation leading to an exposed sub-endothelial matrix. In the endothelial gaps, there 
were large numbers of leukocytes embedded within a fibrin network. The remaining ECs were 
covered with numerous microvilli, indicating an inflammatory response (Figure 2A and 2B). Areas 
with adherent blood cells, which had appeared as red dots by light microscopy, where identified as 
arterial thrombi by SEM. These arterial thrombi were characterized by the presence of RBCs and 
leukocytes embedded in a network of fibrin fibers (Figure 2C). 
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SEM also revealed M. suis aggregates of approximately 5–50 µm in diameter attached to the surface 
of the vessel walls. These micro-colonies were characterized by round or elongated cross-linked cells 
of 200–400 nm in diameter embedded in a three-dimensional granular matrix (Figure 2D). In addition, 
smaller coccoids (less than 100 nm in size) localized to the surface of the larger bacterial cells (Figure 
2E). In some cases, M. suis cells on RBCs were interconnected via small fibrils (Figure 2F). In 
contrast to aortic vessels from M. suis-infected pigs, the aortic vessels of healthy pigs showed no 
evidence of endothelial cell damage. Confluent layers of spindle-shaped ECs (5–8 µm in width and 
10–25 µm in length) arranged in parallel and with no attached blood cells or bacteria were observed in 
non-infected pigs (Figure 2G and 2H).  
Ultrathin sections of the abdominal aorta were further analyzed for EC activation and detachment by 
transmission electron microscopy (TEM). Microvilli formation was evident on the ECs of the 
abdominal aorta of M. suis-infected pigs (Figure 3A). In some ultrathin sections, no ECs were detected 
at all, a finding consistent with the SEM analysis of the aorta of the same pig (Figure 3B). M. suis was 
detected in the subcellular aortic tissue following staining with an anti-MSG1 monoclonal antibody 
and subsequent nanogold silver intensification (Figure 3C, D). M. suis cells appeared to be attached to 
subcellular matrix structures resembling collagen. As with the results of SEM, the vascular wall of 
healthy control pigs was characterized by a continuous layer of ECs with no alterations in 
ultrastructure (Figure 3E).  
 
Intravascular coagulation and morphological changes in the parenchyma in M. suis-infected 
pigs 
To further examine M. suis-induced morphological changes, endothelial morphology and intravascular 
coagulation in the organ capillaries of the liver and heart parenchyma were analyzed by TEM. 
The ECs of the heart capillaries of M. suis-infected pigs were irregular in shape with localized 
swelling and finger-like pseudopodia (Figure 4A, B). M. suis-infected RBCs were adherent to the 
endothelium and surrounded by endothelial pseudopodia.   
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Morphological changes in the heart parenchyma of infected pigs were also observed. In cardiac 
muscle cells (Figure 4A), myofibrils were disarranged and the number of fibrils was reduced. 
Mitochondria were markedly reduced in number and appeared to be randomly distributed in the heart 
tissue. Sarcomere atrophy was evident and the structures inconsistent in many parts of the tissue 
(Figure 4A).  
In control pigs, by comparison, there was a regular pattern of ECs lining the cardiac vessel wall. No 
RBCs were attached to the vessel wall and no M. suis particles were detected (Figure 4C). The 
morphology of the cardiac muscle of control pigs was normal, with alternating I and A bands. 
Sarcomeres were arranged in parallel and myofibrils were separated by the normal striped 
arrangement of mitochondria.  
Intravascular coagulation was detected in the microvascular channels (sinusoids) of the liver of 
M. suis-infected pigs. Aggregated RBCs attached to the vascular wall appeared to block the sinusoids 
(Figure 4D, E). In contrast, plasma in the sinusoids of control pigs had a homogenous appearance and 
RBCs were distinct and separated from the vessel wall (Figure 4F). Liver cells (hepatocytes) from 
M. suis-positive pigs (Figure 4D, E) and control pigs (Figure 4F) had a normal polygonal structure and 
showed no signs of morphological changes. Bile canaliculi, the thin tubes that collect bile secreted by 
hepatocytes, were also displayed.  
 
M. suis interaction with and activation of porcine aortic endothelial cells in vitro  
To investigate the interaction of M. suis with ECs in vitro, PAECs were infected with purified M. suis 
and then analyzed by confocal laser scanning microscopy following immunohistochemical staining to 
differentiate the cytoskeleton, cell nucleus, and M. suis. M. suis cells were detected as aggregates on 
the surface of PAECs as early as 90 min post-infection. Actin condensation was observed at the sites 
of bacterial cell attachment (Figure 5A–C) and always co-localized to sites of bacterial aggregates. 
Propagation of M. suis on the surface of PAECs was not observed over the course of this experiment. 
As a control, no M. suis cells were detected on PAECs incubated with the negative control preparation 
(Figure 5D). 
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To assess whether EC activation occurred as a result of the direct interaction with M. suis, PEDSV.15 
cells were infected with purified M. suis. Expression of different cell adhesion molecules (CAMs), i.e. 
ICAM-1 (CD54), PECAM-1 (CD31), P-selectin (CD62P) and E-selectin (CD62E) was used as 
activation marker. The CAMs expression levels (number of CAMs expressing PEDSV.15 cells) were 
determined using FACS analysis and CAM-specific monoclonal antibodies. Responsiveness of the 
PEDSV.15 cells was proven by the induction of CAMs upregulation after TNF-α and LPS 
stimulation.  
Overall, there was a significant increase in CAMs expressing PEDSV.15 cells upon infection with 
M. suis (P ≤ 0,05). As shown in Figure 6 M. suis-stimulated PEDSV-15 showed a significant increase 
in CAM cell-surface expression compared with that in the negative control bacterial preparation 
M. suis-incubated PEDSV-15 expressed on average 1.9-fold more ICAM-1 (CD54, P = 0.028), 
2.6-fold more E-selectin (CD62E, P = 0.043), 7.5-fold more P-selectin (CD62P, P = 0.028) and 
1.9-fold more PECAM-1 (CD31, P = 0.043) compared with negative control bacterial preparation.  
 
Discussion 
Hemolytic anemia as a result of acute M. suis infection is accompanied by coagulopathy, vascular 
thrombosis, and hemorrhaging of the skin and organs; symptoms that are indicative of the involvement 
of vascular ECs in the pathogenesis of acute M. suis infection [9, 11, 12]. However, the involvement 
of ECs in M. suis pathogenesis has received little attention to date because consumption coagulopathy 
is considered to be the primary cause of hemorrhagic diathesis [12]. Our own recent clinical 
observations of acute IAP with a fatal outcome [1] led to the hypothesis that interactions with ECs 
contribute to IAP pathogenesis. Therefore, the aim of the present study was to investigate the 
interaction between M. suis and ECs, and the resulting endothelial disruption and damage to the 
vasculature.  
SEM and TEM analyses clearly demonstrated marked abnormalities in the endothelium of blood 
vessels in M. suis-infected pigs. Blood vessels exhibited detached ECs over a considerable portion of 
the endothelium. In some ultrathin sections, EC were completely missing and the subcellular matrix 
was exposed. This likely represents the mechanism by which M. suis gained access to the 
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sub-endothelial matrix, where it was detected by TEM. However, the extent of endothelial denudation 
made the microscopic detection of intracellular M. suis in ECs unfeasible. An analogy can be made 
with certain Bartonellae species, which are also undetectable intracellularly in ECs, even though 
pathogenesis induced by these species was shown to involve ECs [36]. Additionally, the abnormalities 
reported herein are typical signs of activated ECs seen in several other diseases, i.e. sickle cell anemia 
[37, 38], and are highly indicative of dysfunctional activation of the endothelium in IAP. 
The formation of microvilli-like membranes on ECs was observed in M. suis-infected animals, which 
is also characteristic of an activated phenotype, and could serve to increase the frequency of adhesion 
of M. suis-infected RBCs, as observed in micro vessels from patients infected with P. falciparum [39]. 
The increased adhesion of M. suis-infected RBCs to the endothelium might be further enhanced by 
M. suis-induced RBC changes, some of which could trigger a variety of pathologies such as 
vasoocclusion, endothelial activation, and initiation of the coagulation cascade [40]. The extent of 
RBC adhesion seen in the liver sinusoids, as well as in heart capillaries, might be a result of a 
combination of activated ECs with microvilli, altered RBC membranes, and an increased adhesiveness 
caused by pseudopodia. Similar pathologic patterns are observed in P. falciparum infections [41]. 
Numerous arterial thrombi, composed of leukocytes, RBCs, platelets and a network of fibrin fibers, 
were attached to ECs next to sites of M. suis-induced endothelial injury. This fibrin network acts as a 
provisional matrix during inflammation and wound healing [42]. Fibrin and fibrinogen metabolites 
bind to activated platelets and also to vascular EC, thereby activating both cell types [42, 43]. 
Activated ECs facilitate the translocation of phagocytes into the injured tissue to eliminate bacteria via 
phagocytosis [44]. Furthermore, in diabetes mellitus and sickle cell anemia, fibrinogen enhances 
adhesion of pathological RBCs to ECs, and this is associated with a high incidence of thrombosis 
[45, 46]. 
The detection of M. suis in direct contact with ECs and attached to the endothelium is an entirely new 
finding in HM research. To date, HM has been reported to attach and invade a unique host cell, the 
RBC [1-3]. In the current study, M. suis was attached to ECs either as a single cell or as microcolonies 
ranging in diameter from 30–50 µm. This direct interaction of M. suis with ECs could trigger the EC 
destruction and exposure of the subendothelial matrix observed in the M. suis-infected pigs. This 
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would be consistent with other pathogenic Mycoplasma species, such as the large colony strains of 
M. mycoides subsp. mycoides, which are able to adhere to and destroy caprine ECs, thereby exposing 
subendothelial collagen and causing vasculitis and coagulation disturbances [18, 20].  
The M. suis biofilm-like structures we observed were homogenous aggregates of cross-linked 
200-400 nm M. suis cells that formed a three-dimensional network. Occasionally, microcolonies 
appeared more compact and the bacteria were embedded in a granular matrix. M. suis microcolonies 
attached to the vascular wall and resembling biofilms have been described for other mycoplasmas 
[47]. Within these microcolonies, smaller coccoid cells less than 100 nm in diameter were observed on 
the surface of the larger cells. These M. suis cells probably originated from a budding-like replication 
mechanism, similar to that proposed for HM, as well as for other mycoplasmas, and they resembled 
propagating M. suis cells on RBC [1, 48, 49]. These results strongly suggested that M. suis is capable 
of propagating on ECs.  
One of the more novel and more interesting findings of this study was the formation of small fibrils 
interconnecting several M. suis cells on the surface of RBCs and attached to the vascular wall. M. suis 
adhere to host RBCs via fibrils [49, 50]. In the current study, the interconnected M. suis cells were 
observed only on the surface of RBCs attached to the endothelium. This type of specialized cell-to-cell 
communication may be necessary for the development of an endothelial biofilm. The gram-negative 
Myxococcus xanthus is able to form extensive fibrillar interconnections, which are necessary for their 
characteristic social behavior [51]. Further studies are needed to better characterize the composition 
and function of M. suis fibrils.  
In vitro analysis using porcine endothelial cells (PAEC and PEDSV.15 cells) provided further insight 
into the mechanism of interaction between M. suis and ECs. A considerable number of M. suis cells 
were attached to the PAEC surface, and actin condensation was evident at the attachment sites. 
Indications for an interaction between M. suis and porcine actin have been found in a previous study 
since M. suis-induced autoreactive IgG antibodies also bind to actin [8, 52]. In the present study, we 
found clear evidence that M. suis interacts with cytoskeletal actin of endothelial cells leading to 
cytoskeletal rearrangements in the EC, which might allow internalization of M. suis. Various invasive 
bacteria, such as Yersinia enterocolitica and Listeria monocytogenes, trigger rearrangement of the 
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actin cytoskeleton to facilitate their uptake into eukaryotic cells [53, 54]. Analysis of the M. suis 
genome revealed that, similar to other Mycoplasma species, M. suis lack any of the genes required for 
de novo nucleotide biosynthesis [55]. Thus, establishing itself in a new niche in a nucleated cell would 
be of critical importance for M. suis in terms of acquiring a source of nucleotides for proliferation. 
Despite demonstrating a clear and close interaction between M. suis and ECs, definitive proof of the 
intracellular localization of M. suis in ECs in vivo could not be demonstrated due to the extensive 
cytopathological effects of M. suis (data not shown). Damaged ECs most likely detached from the 
endothelium and, thus, were not available for microscopic analysis of intracellular M. suis. Additional 
studies of sections from infected blood vessels at an early phase of infection may provide the 
necessary evidence to support this hypothesis.  
The activation of ECs by M. suis was demonstrated in vitro by the significant increase of ICAM-1, 
PECAM, E-selectin and P-selectin expressing cells, all of which are important markers of EC 
activation. Endothelial E-selectin and P-selectin are up-regulated by inflammation and mediate 
leukocyte capture and rolling on the endothelium [56]. The up-regulation of E-selectin is associated 
with organ dysfunction and septic shock [57], both of which are seen in acute IAP. The time point of a 
maximum upregulation of activation markers by LPS and TNF-α might not represent the time point of 
a maximum upregulation by M. suis. This could explain the relatively smaller but significant 
difference between M. suis and negative control in case of E-selectin and PECAM-1. ICAM-1 is 
involved in leukocyte rolling and arrest on endothelial cells [56], as well as the movement of 
neutrophils and monocytes on the endothelium [58]. Recently, ICAM-1 was identified as the receptor 
for rhinovirus [59]. Furthermore, PECAM-1, which is expressed on the surface of ECs and most 
leukocytes, was up-regulated upon in vitro stimulation with M. suis cells. PECAM-1 is involved in the 
removal of apoptotic neutrophils from the body and makes up a large proportion of the endothelial cell 
intercellular junction [60, 61], where it mediates transendothelial migration via homotypic binding to 
PECAM-1 on leukocytes [62]. In summary, these in vitro findings, including the up-regulation of 
endothelial adhesion receptors, together with the observed structural changes of the endothelial layer 
in vivo, i.e. microvilli- and gap-formation, demonstrate that M. suis infection results in activation of 
EC.  
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Another of the more intriguing findings of the current study was the observation of cardiac muscle 
damage with disorganized and damaged and/or destroyed cardiac muscles cells. These effects could be 
explained by RBC aggregation in the blood vessels of M. suis-infected pigs with subsequent occlusion 
of capillaries leading to ischemia (interruption of the blood supply). This would be consistent with the 
fact that some cases of acute M. suis infection in pigs result in death within a few days [1]. 
In conclusion, we report several novel findings of infection with HM leading to widespread 
endothelial damage, RBC adhesion to the endothelium, and vascular occlusion. These vascular 
alterations lead to the development of hemorrhage and organ failure. To our knowledge, this is the 
first demonstration that HM interacts with host cells other than RBCs. In addition, the ability of 
M. suis to form biofilm-like microcolonies on the endothelium, which may protect the organism from 
antimicrobial agents and host immune factors, may contribute to the persistence of HM infections.  
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Figures 
 
Figure 1: Degeneration of capillary endothelial cells in M. suis-infected pigs. 
Representative small intestinal venule of an M. suis-infected pig (histological analysis). Massive cytoplasmic 
swelling of ECs, accompanied by progressive cellular necrosis and detachment of ECs from the underlying 
basement membrane, is evident. Arrowheads indicate areas of cellular denudation of the luminal surface; small 
arrows indicate immunoreactive M. suis cells. Scale bar = 20 µm. 
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Figure 2: Endothelial denudation and microvilli and microcolony formation due to M. suis infection.  
A. Aortic vessel of an infected pig with adherent blood cells and fibrin fibers attached to ECs. 
Scale bar = 20 µm; B. Aortic vessel from an infected pig showing activated ECs (microvilli formation) and 
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detached ECs exposing the subendothelial layer (SEL). Leukocytes are attached to the ECs and the subcellular 
matrix. Scale bar = 10 µm; C. Vascular wall covered with blood clots. Scale bar = 10 µm; D. Bacterial 
microcolonies (BMs) attached to the vascular wall. Scale bar = 2 µm; E. M. suis coccoids of less than 100 nm. 
Scale bar = 2 µm; F. M. suis cells attached to RBCs and interconnected via small fibrils. Scale bar = 2 µm; 
G. Luminal surface of an aortic vessel from a healthy pig showing a confluent layer of ECs (overview). Scale bar 
= 40 µm; H. Aortic vessel from a healthy pig showing a confluent layer of ECs. Scale bar = 10 µm. 
Abbreviations: BM, bacterial microcolony; EC, endothelial cell; Fi, fibrinogen fibers; Leu, leukocytes; MV, 
microvilli; RBCs, red blood cells; F, small fibrils; SEL, subendothelial layer; and VW, vessel wall.  
 
 
Figure 3: M. suis infection induces endothelial cell detachment and activation. 
Transmission electron micrographs of aortic sections. A. ECs (black arrows) of pigs infected with M. suis (black 
arrowheads) are characterized by extensive microvilli (MV) formation. Scale bar = 4 µm; B. Absence of ECs/EC 
detachment and remaining vacuolar cells. Scale bar = 4 µm; C, D. M. suis was detected in the aortic sub-cellular 
tissue by nanogold silver intensification staining. Scale bar = 0.2 µm (C); Scale bar = 0.5 µm (D); E. Endothelial 
cells (ECs) of uninfected control pigs showing normal ultrastructure. Scale bar = 4 µm. Abbreviations: Co, 
collagen; L, lumen; PV, plasmalemma vesicle; N, nucleus; SP, silver precipitates; RM, tunica media; and VC, 
vacuolar cell.   
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Figure 4: Intravascular coagulation and morphological changes in M. suis infected pigs. 
Transmission electron micrographs of porcine liver and heart preparations. A, B. Heart biopsies from an 
M. suis-infected pig with unorganized myofibrils (MF). M. suis cells are indicated by a black arrowhead and thin 
endothelial cells of capillaries (c) and sinusoids (Si) with a black arrow. Scale bar = 4 µm (A); scale bar = 4 µm 
(B); C. Heart biopsy from an uninfected control pig. Myofibrils exhibit the typical banding pattern with 
alternating A and I bands. Scale bar = 4 µm. D, E. Liver preparations from an M. suis-infected pig with red 
blood cell (RBC) aggregates adherent to endothelial cells (ECs). Scale bar = 4 µm (D); scale bar = 1 µm (E); 
F. Liver preparation from an uninfected control pig. Scale bar = 4 µm. Abbreviations: Mi, mitochondria; 
N, nucleus; Ps, pseudopodia; RBC, red blood cell; ER, endoplasmic reticulum; V, intracellular vacuoles; and Bc, 
bile canaliculi.   
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Figure 5: Interaction of M. suis with porcine endothelial cells induces actin condensation in vitro. 
Confocal laser scanning micrographs of PAECs incubated with M. suis (1 × 104 cells/mL). Cytoskeletal actin 
was stained with FITC-phalloidin (green); M. suis cells were stained with anti-HspA1 antiserum and 
TRITC-labeled secondary antibodies (red). Nuclei and bacteria were counterstained with DAPI (blue). The 
image represents an overlay of all fluorescent channels. (A) 90 min post-infection (pi); scale bar = 40 µm; (B) 6 
hours pi; scale bar = 20 µm; (C) 4 days pi; scale bar = 10 µm; (D) Pre-infection; scale bar = 50 µm.   
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Figure 6: CAM expression in M. suis infected endothelial cells. 
The expression profiles of adhesion molecules on endothelial cells were analyzed using a FACSCanto II cell 
sorting system. A. Dashed lines represent the isotype control; solid lines represent cells incubated with the 
negative control bacterial preparation; grey histograms represent PEDSV.15 cells incubated with M. suis 
(1 × 104 cells/mL). B. Percent increase in expression ICAM-1 (CD54), PECAM-1 (CD31), E (CD62E)- and 
P (CD62P)-selectin in ECs infected with M. suis.   
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5 Milestones and Outlook 
Chronic course of M. suis infections result from the ability of M. suis to make use of different 
strategies that enable agent life-long persistence. Several processes contributing to M. suis persistence 
were evidenced in the present thesis and are summarized in figure 9: (1) in vivo and in vitro 
impairment of host immune response upon M. suis-host interaction was documented; (2) The 
formation of M. suis microcolonies, that were found attached to the endothelium as well as PBMCs, 
also contributes to the persistence of the pathogen. Targeting components of the immune system 
enables M. suis to evade and modulate this system leading to a productive niche for the persistent 
agent propagation and to autoreactive processes. 
In addition, dysfunctional activation of endothelium induced by M. suis infection resulted in the 
immunopathological features e.g. hemorrhagic diathesis, coagulopathy, tissue damage, and organ 
failure.  
 
• The present study provides for the first time evidence of M. suis interaction with cell types 
other than RBCs. M. suis microcolonies attach to endothelial cells (ECs) and PBMCs, thereby 
inducing activation of ECs and clotting several PBMCs together. M. suis single cells and cell 
clusters were found localized inside PBMCs. Since the M. suis positive PBMCs subtype is not 
identified, it is not clear whether M. suis internalization is an active bacterial process or rather 
attributed to phagocytosis. Further approaches of our research group deal with the 
identification of the type of internalization of M. suis by PBMCs.  
 
• M. suis interacts with PBMCs and induces premature activation of T-regulatory cells. 
T-regulatory cells inhibit the proliferation of T-helper cells via production of IL-10. The initial 
in vitro activation of Th1 immune response is downregulated early before an M. suis specific 
Th1 immune response establishes. The down regulation of IL-12 production correlates 
negatively with the clearance of intracellular M. suis, thus enabling survival of intracellular 
M. suis. In parallel B-lymphocytes are activated polyclonally upon M. suis encounter in 
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T-helper cell independent manner. The polyclonally activated B-lymphocytes produce 
autoreactive antibodies, those are responsible for the M. suis induced autoimmunity in IAP. 
M. suis induced upregulation of proinflammatory cytokines e.g. IL-1, IL-6, and TNF-α most 
probably contribute to the immunopahtology in IAP. The upcoming in vivo investigations 
shall confirm the outcome of in vitro assays. 
 
• The coagulopathy induced by M. suis infection results from the pathological activation of 
endothelial cells upon interaction with M. suis.  The majority of PBMCs were trapped in the 
coagula, a condition that led to leukopenia. The pathological activation of the endothelium and 
coagulopathy are responsible for the thrombocytopenia, leukopenia, and hemorrhagic 
diathesis, of which the latter contributes to the spread of the M. suis into the surrounding 
tissue. 
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Figure 9: Milestones of the thesis. A. M. suis was detected inside PBMCs and ECs; B. M. suis modulates the 
immune response of the host and forms biofilm-like structures to persist. (1) Components of the immunes system 
targeted by M. suis are shown in red. Interaction with M. suis leads to induction of: IL-1, IL-6, IL-10, 
TNF-α and inhibition of IL-4, IL-12, and IFN−γ; (2) M. suis microcolonies resemble biofilm formations; 
C. Pathological alterations occurred during M. suis infection. 
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9 Appendix I 
 
A 
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Appendix I: Quantitative imaging analysis of PBMCs in flow using FlowSight 
FlowSight cytometer provides visual verification of the morphology of each cell analyzed and enables 
gating of cells from debris. A. In samples from M. suis infected pig (No 6019) 12.7 % of the PBMCs were 
M. suis positive, whereas PBMCs from M. suis negative pig were all negative; B. In chanel (Ch) 01 
birghtfield images of 2 M. suis positive PBMCs from Pig No 6019 are shown. The analyzed M. suis 
positive PBMCs were whole, intact single (10162) or cluster (10264) of cells.  
 
  
